Revision as of 14:55, 19 January 2010 editLittleolive oil (talk | contribs)Extended confirmed users, Pending changes reviewers25,081 edits →Transcendental_Meditation: cmt← Previous edit | Latest revision as of 10:22, 7 January 2025 edit undoMoribundum (talk | contribs)Extended confirmed users539 edits →Mandibular cancer: ReplyTag: Reply | ||
Line 1: | Line 1: | ||
{{skip to top and bottom}} | |||
{{MedTalkheader|archivedays=10}} | |||
{{ |
{{skip to bottom}} | ||
{{VEFriendly}} | |||
{{User:HBC Archive Indexerbot/OptIn | |||
|target=Misplaced Pages talk:WikiProject Medicine/Archive index | |||
|mask=Misplaced Pages talk:WikiProject Medicine/Archive <#> | |||
|mask=Misplaced Pages talk:WikiProject Preclinical Medicine/Archive <#> | |||
|mask=Misplaced Pages talk:WikiProject Clinical medicine/Archive <#> | |||
|leading_zeros=0|indexhere=no | |||
}} | |||
{{User:MiszaBot/config | {{User:MiszaBot/config | ||
|archiveheader = {{aan}} | |||
|maxarchivesize = 250K | |||
|maxarchivesize = 150K | |||
|counter = 16 | |||
| |
|counter = 172 | ||
|minthreadstoarchive = 1 | |||
|minthreadsleft=5 | |||
|algo = old(30d) | |||
|archive = Misplaced Pages talk:WikiProject Medicine/Archive %(counter)d | |archive = Misplaced Pages talk:WikiProject Medicine/Archive %(counter)d | ||
}} | }} | ||
{{MedTalkheader|archivedays=30<!--should be equal to the # in "algo=old(#d)" from above-->}} | |||
{{bountywp|condition=the ] article is improved to featured status|expires= 31 December 2010}} | |||
{{Press | |||
|author = Sarah Shamim, Dwayne Oxford | |||
== ] == | |||
|title = Misplaced Pages war: Fierce row erupts over Israel’s deadly Nuseirat assault | |||
|date = June 14, 2024 | |||
Would you be willing to have external links to 27 articles on the design and action of surgical retractors with photographs and descriptions of 20 different retractors? eg http://www.wikisurgery.com/index.php?title=Retractors_11_Tissue_holding-_Littlewood These are on our website at Wikisurgery.com. We have established external links to Misplaced Pages in the past and have had great interest from wikipedia users. I hope I have not transgressed any rules with this approach. ] (])] (]) 17:30, 2 January 2010 (UTC) | |||
|org = ] | |||
|url = https://www.aljazeera.com/news/2024/6/14/wikipedia-war-fierce-row-erupts-over-israels-deadly-nuseirat-assault | |||
:Thank you for asking here: we encourage making an approach as you have. My first thought was no, because of our policy on ], section '' Links normally to be avoided'': "Any site that does not provide a unique resource beyond what the article would contain if it became a featured article". Having taken a good look at the site, I would ask the question "Could the material be incorporated into Misplaced Pages?". The answer is unclear to me, since the text on the WikiSurgery site is apparently "available under the terms of the GNU Free Documentation License", but is empty. In addition, there is no copyright information for the images, although doesn't find them elsewhere. On the other hand, I can see value in the Wikisurgery site, so I would be tempted to agree with making links from our articles, as long as we can be sure we're not linking to a website containing copyright violations. Until we can verify the copyright terms of the text and images on WikiSurgery, I'd suggest we should wait before adding these as external links. --] (]) 19:20, 2 January 2010 (UTC) | |||
|lang = <!-- default is English --> | |||
|quote = Misplaced Pages was able to address the issue of misinformation about the virus spreading on its platform, however, with projects like Wiki Project Medicine, a community of doctors and scientists,working to correct wrong information. | |||
::I can't imagine any single article benefiting from 27 separate links. ] (]) 21:36, 2 January 2010 (UTC) | |||
|archiveurl = <!-- URL of an archived copy of the page, if the original URL becomes unavailable. --> | |||
|archivedate = <!-- do not wikilink --> | |||
:::Thank you very much for your comprehansive replies. I wrote all the text and made all the images. I hold the copyright for all of them and all the other text and images on the basic surgical skills program on wikisurgery. Will that be enough or would you prefer more formal evidence? About the 27 articles, a single link to the introductory article (http://www.wikisurgery.com/index.php?title=Retractors_04_Introduction) would lead the wikipedia user to all the others.] (])] (]) 17:35, 5 January 2010 (UTC) | |||
|accessdate = June 14, 2024 | |||
}} | |||
::::I am no copyright expert, but I don't understand how you could "hold" the copyright to all of that content given (and no apparent exceptions for the content in question) that it's under the ]. Based on the that copyleft provision, portions of wikisurgery could be copied to wikipedia as long as there is attribution, couldn't they? That might lead to more legible content on WP than a bunch of links. -- ] (]) 02:13, 6 January 2010 (UTC) | |||
:::::The reason that Michael Harpur Edwards can claim to hold the copyrights at present is that he appears to be the only contributor (so far) on WikiSurgery, as a quick look at a few page histories shows (assuming that 'Michael edwards' and 'M h edwards' are synonymous). I doubt that content imported from there would pass ], so if we felt that the images were useful, then an external link would really be the best solution. I'm leaning toward accepting MHE's word that we would not linking to copyvios, and recommending that we encourage inserting the external link(s). --] (]) 05:53, 6 January 2010 (UTC) | |||
:May I take it from your discussions that you would be happy for me to insert an external link from Wikisurgery to the Misplaced Pages article on Retractors (Medical)? Please look at this article ] to check the link is OK with you? ] (]) 12:35, 12 January 2010 (UTC) | |||
::Not everyone is going to agree 100% of the time, but the test is always "Does it improve the article?". In my very humble opinion, your external link improves that article. Thanks for taking the time to discuss this beforehand. --] (]) 17:02, 12 January 2010 (UTC) | |||
== ] == | |||
It appears that a fast acting SPA is totally rewriting the article using primary research and slurring the distinction between unproven alternative medicine usage and proven mainstream usage. See the thread here: | |||
* ] | |||
] (]) 17:04, 3 January 2010 (UTC) | |||
: I don't remember if this topic was regarding DC fields ( IIRC the bone things were static currents, not sure about magnet stuff), but here is an interesting result, | |||
http://www.ncbi.nlm.nih.gov/pubmed/20061638 of course cancer and stimulation are not mutually exclusive. In the absence of good causal arguments, you will get all kinds | |||
of confusing results because you can't control all the ( unknown ) variables and have to hope they just cancel out in larger placebo controlled trials. ] (]) 12:28, 12 January 2010 (UTC) | |||
== Warburg's Tincture == | |||
Hi. I recently created and originated an article on Misplaced Pages about ]. I'm writing here to enquire if the article should added to the Medicine WikiProject? I feel Warburg's Tincture is important in the history of medicine.--] (]) 18:11, 5 January 2010 (UTC) | |||
:It is directly related to medicine, if you feel the same way, be bold and add the WP:MED banner on the discussion page without consulting anyone. Chances are, you will be correct. If you are not, it will be corrected with no strike against you. ] <font color="#960018"></font> <small></font>]]</small> 18:19, 5 January 2010 (UTC) | |||
::{{done}} ] (]) 18:24, 5 January 2010 (UTC) | |||
::I also made a few changes to the formatting; you might like to look them over and copy the style. Also, ] might interest you. ] (]) 18:32, 5 January 2010 (UTC) | |||
I have expanded and improved this article a lot more now. Please can the article quality rating be reviewed. Thanks--] (]) 10:22, 8 January 2010 (UTC) | |||
Hi. Please can people advise how the article ] can be improved? I don't know that I can improve it any more. I don't come form a medical or science background. Thanks--] (]) 00:09, 15 January 2010 (UTC) | |||
== Regarding ] == | |||
Does the term ] refer to ] or ]? ---] (]) 18:41, 6 January 2010 (UTC) | |||
: Senile keratosis is not a term that I'm particularly aware of. According to ]'s Skin Pathology (3rd Ed), Seb K may also be known as ], amongst other things, so this could be a candidate. I call actinic keratosis solar keratosis, and these do appear most often on the sun -exposed skin of older people, but they can also occur in younger solarium users. The two are obviously quite different and if I was going to use the term senile keratosis, I'd be more likely to apply it to a benign condition than a premalignant one. Cheers, ]]] 04:31, 9 January 2010 (UTC) | |||
::Ok, I am changing the redirect, based on your feedback and Bolognia, to ] --> ]. ---] (]) 21:35, 9 January 2010 (UTC) | |||
== ] == | |||
I've just created this book, but I'm not prostate expert. So if someone could quickly check if I haven't forgotten something, that would be great. Thanks. ] {<sup>]</sup><sub style="margin-left:-4.0ex;">]</sub> – ]} 17:39, 9 January 2010 (UTC) | |||
== Brainstorming == | |||
I would like to have a list of dermatologists after which a cutaneous condition has been named. Restated, if a condition has been named after someone, that person is included in the list. I think this would be a nice reference for people. Do you think this would be ok? If so, what would you name the list? ---] (]) 21:39, 9 January 2010 (UTC) | |||
: To answer a question you didn't ask, "how would you generate this list?" I would attempt to use some pubmed scripts to look at derma abstracts and find uncommon words, pref capitalized terms not starting sentences. ] (]) 21:44, 9 January 2010 (UTC) | |||
::Well, I will get most of them from the ] which is probably six months from being near comprehensive for cutaneous condition names/synonyms. But what should the list be titled? ---] (]) 21:53, 9 January 2010 (UTC) | |||
:::<nowiki>], or ]</nowiki> if you want it to be intelligible to students and English-language learners. ] (]) 22:36, 9 January 2010 (UTC) | |||
:Are you thinking of something like ? You know, when it has been done already, and better than one could possibly imagine achieving here, it seems a bit pointless to repeat the exercise. More useful IMO would be to write short encyclopaedic articles about these physicians than to just list them. | |||
== Category:Telehealth == | |||
I discovered a new category, ], and was unsure whether it is a good idea ... so I listed it at ]. Your contributions to the discussion would be welcome. --] <small>] • (])</small> 23:15, 10 January 2010 (UTC) | |||
== Anti-NMDA receptor encephalitis == | |||
Started ], help is welcomed. Cheers, --<font color="000066">]</font> 18:05, 11 January 2010 (UTC) | |||
:Thanks for working on that - it looks good (and as recently described entity, there may not be much more to add for now). ''']''' <sup>]</sup> 18:14, 11 January 2010 (UTC) | |||
: here are the citations for 20 most recent pubmed hits that mention nmda and encephalitis, | |||
{{cite journal | last=Poloni | first=C | last2=Ricotti | first2=V | last3=King | first3=MD | last4=Perez | first4=ER | last5=Mayor-Dubois | first5=C | last6=Haenggeli | first6=CA | last7=Deonna | first7=T | last8= | first8= | title=Severe childhood encephalopathy with dyskinesia and prolonged cognitive disturbances: evidence for anti-N-methyl-d-aspartate receptor encephalitis. | journal=Developmental medicine and child neurology | volume= | issue= | pages=- | date=23-Dec-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/20041934 | pmid=20041934 | doi=10.1111/j.1469-8749.2009.03542.x | pmc=10.1111/j.1469-8749.2009.03542.x }} | |||
{{cite journal | last=Graus | first=F | last2=Dalmau | first2=J | last3= | first3= | title=Antibodies and neuronal autoimmune disorders of the CNS. | journal=Journal of neurology | volume= | issue= | pages=- | date=25-Dec-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/20035430 | pmid=20035430 | doi=10.1007/s00415-009-5431-9 | pmc=10.1007/s00415-009-5431-9 }} | |||
{{cite journal | last=Iizuka | first=T | title= | journal=Rinshō shinkeigaku = Clinical neurology | volume=49 | issue=11 | pages=774-8 | date=Nov-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/20030207 | pmid=20030207 | doi= | pmc= }} | |||
{{cite journal | last=Zandi | first=MS | last2=Follows | first2=G | last3=Moody | first3=AM | last4=Molyneux | first4=P | last5=Vincent | first5=A | last6= | first6= | title=Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. | journal=Neurology | volume=73 | issue=23 | pages=2039-40 | date=8-Dec-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19996080 | pmid=19996080 | doi=10.1212/WNL.0b013e3181c55e9b | pmc=10.1212/WNL.0b013e3181c55e9b }} | |||
{{cite journal | last=de Broucker | first=T | last2= | first2= | title= | journal=Medecine et maladies infectieuses | volume= | issue= | pages=- | date=24-Nov-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19942390 | pmid=19942390 | doi=10.1016/j.medmal.2009.10.013 | pmc=10.1016/j.medmal.2009.10.013 }} | |||
{{cite journal | last=Lebas | first=A | last2=Didelot | first2=A | last3=Honnorat | first3=J | last4=Tardieu | first4=M | last5= | first5= | title=Expanding Spectrum of Encephalitis With NMDA Receptor Antibodies in Young Children. | journal=Journal of child neurology | volume= | issue= | pages=- | date=15-Oct-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19833974 | pmid=19833974 | doi=10.1177/0883073809343319 | pmc=10.1177/0883073809343319 }} | |||
{{cite journal | last=Masuda | first=T | last2=Ishibashi | first2=M | last3=Ito | first3=M | last4=Takahashi | first4=Y | last5=Kumamoto | first5=T | last6= | first6= | title= | journal=Rinshō shinkeigaku = Clinical neurology | volume=49 | issue=8 | pages=483-7 | date=Aug-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19827598 | pmid=19827598 | doi= | pmc= }} | |||
{{cite journal | last=Parratt | first=KL | last2=Lewis | first2=SJ | last3=Dalmau | first3=J | last4=Halmagyi | first4=GM | last5=Spies | first5=JM | last6= | first6= | title=Acute psychiatric illness in a young woman: an unusual form of encephalitis. | journal=The Medical journal of Australia | volume=191 | issue=5 | pages=284-6 | date=7-Sep-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19740054 | pmid=19740054 | doi= | pmc= }} | |||
{{cite journal | last=Bayreuther | first=C | last2=Dellamonica | first2=J | last3=Borg | first3=M | last4=Bernardin | first4=G | last5=Thomas | first5=P | last6= | first6= | title=Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. | journal=Epileptic disorders : international epilepsy journal with videotape | volume=11 | issue=3 | pages=261-5 | date=Sep-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19736168 | pmid=19736168 | doi=10.1684/epd.2009.0266 | pmc=10.1684/epd.2009.0266 }} | |||
{{cite journal | last=Gable | first=MS | last2=Radner | first2=A | last3=Tilley | first3=DH | last4=Lee | first4=B | last5=Dyner | first5=L | last6=Collins | first6=A | last7=Dengel | first7=A | last8=Dalmau | first8=J | last9=Glaser | first9=CA | last10= | first10= | title=Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis. | journal=European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology | volume= | issue= | pages=- | date=29-Aug-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19718525 | pmid=19718525 | doi=10.1007/s10096-009-0799-0 | pmc=10.1007/s10096-009-0799-0 }} | |||
{{cite journal | last=Labate | first=A | last2=Vincent | first2=A | last3=Gambardella | first3=A | last4=Piane | first4=EL | last5=Cianci | first5=V | last6=Aguglia | first6=U | last7= | first7= | title=Anti-NMDA receptor encephalitis: a video case report. | journal=Epileptic disorders : international epilepsy journal with videotape | volume=11 | issue=3 | pages=267-9 | date=Sep-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19713171 | pmid=19713171 | doi=10.1684/epd.2009.0268 | pmc=10.1684/epd.2009.0268 }} | |||
==]== | |||
{{cite journal | last=Splinter | first=WM | last2= | first2= | title=Anti-NMDA receptor antibodies encephalitis. | journal=Paediatric anaesthesia | volume=19 | issue=9 | pages=911-3 | date=Sep-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19691699 | pmid=19691699 | doi=10.1111/j.1460-9592.2009.03085.x | pmc=10.1111/j.1460-9592.2009.03085.x }} | |||
I recently created a draft for ], which has recently gotten a lot of press in the aftermath of the ]. There is currently an article for the book ], but I believe the practice is notable enough for its own article. I'd appreciate any help with sourcing. Thank you, ] (]) 20:22, 6 December 2024 (UTC) | |||
:--] (]) 13:06, 17 December 2024 (UTC) | |||
==Images== | |||
{{cite journal | last=Tüzün | first=E | last2=Baehring | first2=JM | last3=Bannykh | first3=S | last4=Rosenfeld | first4=MR | last5=Dalmau | first5=J | last6= | first6= | title=Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. | journal=Acta neuropathologica | volume= | issue= | pages=- | date=14-Aug-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19680671 | pmid=19680671 | doi=10.1007/s00401-009-0582-4 | pmc=10.1007/s00401-009-0582-4 }} | |||
We at Wiki Project Med Foundation are supporting an illustrator. Do folks here have drawings they wish to see created? ] (] · ] · ]) 20:16, 9 December 2024 (UTC) | |||
:] | |||
{{cite journal | last=Ichiyama | first=T | last2=Matsushige | first2=T | last3=Kajimoto | first3=M | last4=Fukunaga | first4=S | last5=Furukawa | first5=S | last6= | first6= | title=Serum matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in non-herpetic acute limbic encephalitis. | journal=Journal of neurology | volume=256 | issue=11 | pages=1846-50 | date=Nov-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19672673 | pmid=19672673 | doi=10.1007/s00415-009-5207-2 | pmc=10.1007/s00415-009-5207-2 }} | |||
:In 2015, an illustrator made this diagram for us. Perhaps this will spark an idea for someone. ] (]) 22:10, 9 December 2024 (UTC) | |||
== Looking for a Tuesday Challenge? ] - Giant Pelvis == | |||
{{cite journal | last=Florance | first=NR | last2=Lam | first2=C | last3=Szperka | first3=C | last4=Zhou | first4=L | last5=Ahmad | first5=S | last6=Campen | first6=CJ | last7=Moss | first7=H | last8=Peter | first8=N | last9=Gleichman | first9=AJ | last10=Glaser | first10=CA | last11=Lynch | first11=DR | last12=Rosenfeld | first12=MR | last13=Dalmau | first13=J | last14= | first14= | title=Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. | journal=Annals of neurology | volume=66 | issue=1 | pages=11-8 | date=Jul-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19670433 | pmid=19670433 | doi=10.1002/ana.21756 | pmc=10.1002/ana.21756 }} | |||
Hi! I came across this article from the ]. It has some very very very outdated citations! I looked briefly on pubmed and also did some hand searching on google for anything anywhere near a MEDRS source. I am now out of time and figured I would post it here in case someone else wants to try this challenge! Perhaps there is a more common name for this condition of a distorted pelvis that is being missed? Not sure how they got the incidence quote etc. Happy editing! | |||
{{cite journal | last=De Nayer | first=AR | last2=Sindic | first2=CJ | last3= | first3= | title=A subacute behavioral disorder in a female adolescent. Autoimmune anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. | journal=Biological psychiatry | volume=66 | issue=6 | pages=e13-4 | date=15-Sep-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19539270 | pmid=19539270 | doi=10.1016/j.biopsych.2009.04.031 | pmc=10.1016/j.biopsych.2009.04.031 }} | |||
] | |||
{{cite journal | last=Iizuka | first=T | last2= | first2= | title= | journal=Rinsho byori. The Japanese journal of clinical pathology | volume=57 | issue=3 | pages=252-61 | date=Mar-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19363996 | pmid=19363996 | doi= | pmc= }} | |||
] (]) 13:42, 10 December 2024 (UTC) | |||
{{cite journal | last=Sakuma | first=H | title=Acute encephalitis with refractory, repetitive partial seizures. | journal=Brain & development | volume=31 | issue=7 | pages=510-4 | date=Aug-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19327924 | pmid=19327924 | doi=10.1016/j.braindev.2009.02.010 | pmc=10.1016/j.braindev.2009.02.010 }} | |||
:--] (]) 13:14, 11 December 2024 (UTC) | |||
::Thanks {{Ping|Ozzie10aaaa}}. I found a book on amazon that was written from the Misplaced Pages article. Yikes! https://www.amazon.com.au/Pelvis-Justo-Major-Fernande-Antigone/dp/613793196X Not using this source- ha! ] (]) 15:38, 12 December 2024 (UTC) | |||
:::yes, that happens alot,Ozzie--] (]) 15:49, 12 December 2024 (UTC) | |||
== Merge proposed for Disorders of Sex Development and Sexual Anamolies == | |||
{{cite journal | last=Sas | first=AR | last2=Smothers | first2=CT | last3=Woodward | first3=J | last4=Tyor | first4=WR | last5= | first5= | title=Interferon-alpha causes neuronal dysfunction in encephalitis. | journal=The Journal of neuroscience : the official journal of the Society for Neuroscience | volume=29 | issue=12 | pages=3948-55 | date=25-Mar-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19321791 | pmid=19321791 | doi=10.1523/JNEUROSCI.5595-08.2009 | pmc=10.1523/JNEUROSCI.5595-08.2009 }} | |||
] for anyone interested. ] (]) 16:23, 10 December 2024 (UTC) | |||
{{cite journal | last=Kataoka | first=H | last2=Taoka | first2=T | last3=Ueno | first3=S | last4= | first4= | title=Reduced N-acetylaspartate in the basal ganglia of a patient with anti-NMDA receptor encephalitis. | journal=Movement disorders : official journal of the Movement Disorder Society | volume=24 | issue=5 | pages=784-6 | date=15-Apr-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19217070 | pmid=19217070 | doi=10.1002/mds.22167 | pmc=10.1002/mds.22167 }} | |||
:thanks for post--] (]) 13:06, 11 December 2024 (UTC) | |||
== Introducing Let's Connect == | |||
] (]) 19:11, 11 January 2010 (UTC) | |||
Hello everyone, | |||
== Colitis-X == | |||
I hope that you are in good spirits. My name is ] and I am a part of the ] - a team of movement contributors/organizers and liaisons for 7 regions : '''MENA | South Asia | East, South East Asia, Pacific | Sub-Saharan Africa | Central & Eastern Europe | Northern & Western | Latina America. ''' | |||
] is a new article nominated for DYK, written by an editor who does not usually write medical articles. I have given it a twice over but it needs more. One important issue remaining is that some of the sources are case reports. Are there no review articles? --] (]) 07:03, 12 January 2010 (UTC) | |||
=== Why are we outreaching to you? === | |||
:Ouch. I have been warned to clear out or I will be blocked. --] (]) 03:18, 14 January 2010 (UTC) | |||
Wikimedia has 18 projects, and 17 that are solely run by the community, other than the Wikimedia Foundation. We want to hear from sister projects that some of us in the movement are not too familiar with and would like to know more about. We always want to hear from Misplaced Pages, but we also want to meet and hear from the community members in other sister projects too. We would like to hear your story and learn about the work you and your community do. You can review our past learning clinics ]. | |||
We want to invite community members who are: | |||
::I'm sorry to hear that this is turning into a personalized dispute. The reactions on your talk page are intriguing: one editor wants to talk sense about the misuse of sources, and another wants to talk about past problems. | |||
::However, the condition appears to be a horses-only veterinary issue, so you might want to post at ]. ] (]) 08:50, 14 January 2010 (UTC) | |||
* Part of an organized group, official or not | |||
== Cephalalgia free online until 31st March 2010 == | |||
* A formally recognized affiliate or not | |||
* An individual who will bring their knowledge back to their community | |||
* An individual who wants to train others in their community on the learnings they received from the learning clinics. | |||
'''To participate as a sharer and become a member of the Let’s Connect community you can sign up through this .''' | |||
Cephalalgia, the journal of the International Headache Society, has moved to SAGE Publications and the entire archive from 1981 - today is free full text online until 31st March 2010. http://cep.sagepub.com/ --] (]) 14:11, 12 January 2010 (UTC) | |||
Once you have registered, if you are interested, you can get to know the team via google meets or zoom to brainstorm an idea for a potential learning clinic about this project or just say hello and meet the team. Please email us at Letsconnectteam@wikimedia.org. We look forward to hearing from you :) | |||
== ] and 'statin' drugs == | |||
Many thanks and warm regards, | |||
An editor has been doing quite a bit of work on revamping the ] article. I don't know enough about this subject to do much about it, but would like to see more eyes on the situation. It is especially the editor's COI that concerns me. He uses some red flag terminology (implying scientific evidence for alternative medicine, which would make it mainstream and no longer "alternative"). Here are some links to read: | |||
Let’s Connect Working Group Member | |||
* {{Userlinks|David notMD}} | |||
] ] | |||
* : | |||
] (]) 09:14, 11 December 2024 (UTC) | |||
==Contra TAAR1 agonism as the mediator of amphetamine actions== | |||
: ''"Evidence-based science in support of complementary and alternative medicine, with focus on dietary supplements and functional foods. PhD in nutritional biochemistry; 25 years working in industry; currently a science consultant to companies wanting to make health claims for their products."'' | |||
Requesting input on this topic ] at WikiProject Pharmacology. Thanks. – ] (], ]) 10:47, 13 December 2024 (UTC) | |||
:commented--] (]) 13:33, 14 December 2024 (UTC) | |||
== ] and comparable genes with inhibitors in clinical trials == | |||
Note that I'm not implying any wrongdoing or bad faith on the part of this editor, just concerns that the article might be skewed in a way that promotes alternative medicine in an improper manner. Please take a look at the formatting, content, and especially references in light of ], ] and ]. -- ] (]) 01:57, 13 January 2010 (UTC) | |||
: Here are the 20 most recent pubmed cites that mention both terms, I'd put it on talk page but trying to get people to use my tool for this. You can copy or move these to talk page and discuss each for inclusion or balance of prominence etc. | |||
{{cite journal | last=Tsai | first=RL | last2=Pan | first2=TM | last3= | first3= | title=Red Mold Rice Mitigates Oral Carcinogenesis in 7,12-Dimethyl-1,2-Benzanthracene-induced Oral Carcinogenesis in Hamster. | journal=Evidence-based complementary and alternative medicine : eCAM | volume= | issue= | pages=- | date=17-Dec-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/20019075 | pmid=20019075 | doi=10.1093/ecam/nep215 | pmc=10.1093/ecam/nep215 }} | |||
I started this discussion at ], and it was suggested that I inquire here. Basically, Misplaced Pages has tens of thousands of articles on individual human genes, many bot-made and maintained with very little human attention. ] caught my eye because a happened to read about clinical trials underway for inhibitors thought to be cancer-preventative. As noted in the other discussion, Misplaced Pages coverage of gene-directed trial therapies ranges from something like ] (which currently contains no information on investigative efforts), to ] (which is reasonably well-covered in this respect). ] ] 20:34, 13 December 2024 (UTC) | |||
{{cite journal | last=Gao | first=X | last2=Pashkov | first2=I | last3=Sawaya | first3=MR | last4=Laidman | first4=J | last5=Zhang | first5=W | last6=Cacho | first6=R | last7=Yeates | first7=TO | last8=Tang | first8=Y | last9= | first9= | title=Directed evolution and structural characterization of a simvastatin synthase. | journal=Chemistry & biology | volume=16 | issue=10 | pages=1064-74 | date=30-Oct-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19875080 | pmid=19875080 | doi=10.1016/j.chembiol.2009.09.017 | pmc=10.1016/j.chembiol.2009.09.017 }} | |||
:--] (]) 14:04, 14 December 2024 (UTC) | |||
:: Thank you - I will get around to adding some specifics. Cheers! ] ] 15:57, 16 December 2024 (UTC) | |||
== Drowning == | |||
{{cite journal | last=Barrios-González | first=J | last2= | first2= | title=Biotechnological production and applications of statins. | journal=Applied microbiology and biotechnology | volume= | issue= | pages=- | date=10-Oct-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19820926 | pmid=19820926 | doi=10.1007/s00253-009-2239-6 | pmc=10.1007/s00253-009-2239-6 }} | |||
The WHO has released their first-ever . It has national statistics, risk factors, evidence-based prevention recommendations, and more. | |||
{{cite journal | last=Sakai | first=K | last2=Nihira | first2=T | last3= | first3= | title=Identification of mokB involved in monacolin K biosynthesis in Monascus pilosus. | journal=Biotechnology letters | volume=31 | issue=12 | pages=1911-6 | date=Dec-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19693441 | pmid=19693441 | doi=10.1007/s10529-009-0093-3 | pmc=10.1007/s10529-009-0093-3 }} | |||
], ], ], ] ], would this interest any of you? ] (]) 22:27, 13 December 2024 (UTC) | |||
{{cite journal | last=Klimek | first=M | last2=Ogunkanmi | first2=A | last3= | first3= | title=Safety and Efficacy of Red Yeast Rice (Monascus purpureus) as an Alternative Therapy for Hyperlipidemia. | journal=P & T : a peer-reviewed journal for formulary management | volume=34 | issue=6 | pages=313-27 | date=Jun-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19572049 | pmid=19572049 | doi= | pmc= }} | |||
:Thanks, I will take a look. · · · ] ]: 02:54, 14 December 2024 (UTC) | |||
{{cite journal | last=Xie | first=X | last2=Xu | first2=W | last3=Dorrestein | first3=PC | last4=Tang | first4=Y | last5= | first5= | title=Acyltransferase mediated polyketide release from a fungal megasynthase. | journal=Journal of the American Chemical Society | volume=131 | issue=24 | pages=8388-9 | date=24-Jun-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19530726 | pmid=19530726 | doi=10.1021/ja903203g | pmc=10.1021/ja903203g }} | |||
:I will take a look too. Thank you ] (]) 14:44, 30 December 2024 (UTC) | |||
== Do The Lancet's Personal View articles meet the standards for a secondary source? == | |||
{{cite journal | last=Grieco | first=A | last2=Pompili | first2=M | last3=Biolato | first3=M | last4=Vecchio | first4=FM | last5=Grattagliano | first5=I | last6=Gasbarrini | first6=G | last7= | first7= | title=Acute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at all. | journal=Journal of hepatology | volume=50 | issue=6 | pages=1273-7 | date=Jun-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/19398239 | pmid=19398239 | doi=10.1016/j.jhep.2009.02.021 | pmc=10.1016/j.jhep.2009.02.021 }} | |||
Hi WikiProject Medicine, | |||
{{cite journal | last=Hong | first=MY | last2=Zhang | first2=Y | last3=Heber | first3=D | last4= | first4= | title=Chinese red yeast rice versus lovastatin effects on prostate cancer cells with and without androgen receptor overexpression. | journal=Journal of medicinal food | volume=11 | issue=4 | pages=657-66 | date=Dec-2008 | year=2008 | url=http://www.ncbi.nlm.nih.gov/pubmed/19053857 | pmid=19053857 | doi=10.1089/jmf.2007.0702 | pmc=10.1089/jmf.2007.0702 }} | |||
The Lancet has a kind of article called a 'Personal View' that is peer reviewed. It has a lot of the formalities of a review article -- description of search strategy and selection criteria, extensive citations for claims, etc. Does this count as a review, and if not, does it still count as a suitable secondary source for biomedical information? ] (]) 11:12, 14 December 2024 (UTC) | |||
{{cite journal | last=Xie | first=X | last2=Gao | first2=X | last3=Guerrero | first3=JL | last4=Yeates | first4=TO | last5=Tang | first5=Y | last6= | first6= | title=Rational improvement of simvastatin synthase solubility in Escherichia coli leads to higher whole-cell biocatalytic activity. | journal=Biotechnology and bioengineering | volume=102 | issue=1 | pages=20-8 | date=1-Jan-2009 | year=2009 | url=http://www.ncbi.nlm.nih.gov/pubmed/18988191 | pmid=18988191 | doi=10.1002/bit.22028 | pmc=10.1002/bit.22028 }} | |||
:Oh I forgot to add. 'Personal View' articles come up when you search The Lancet for review articles only, so clearly The Lancet's editors consider them as part of the Review category. But does WikiProject Medicine? ] (]) 11:34, 14 December 2024 (UTC) | |||
{{cite journal | last=Yang | first=Z | last2= | first2= | title= | journal=Sheng wu gong cheng xue bao = Chinese journal of biotechnology | volume=24 | issue=3 | pages=349-54 | date=Mar-2008 | year=2008 | url=http://www.ncbi.nlm.nih.gov/pubmed/18589807 | pmid=18589807 | doi= | pmc= }} | |||
::Should be fine for non-contentious knowledge and non-novel claims. Novel personal views may be due and should probably be attributed. Any examples in mind? ] (]) 11:37, 14 December 2024 (UTC) | |||
:::Thank you for this. | |||
:::I was asking in general but here is an example: | |||
:::Hashimoto’s disease has a widely discussed issue with persistent symptoms in about 10-15% of patients despite euthyroid status. There’s a number of commonly discussed hypotheses for why this might be. An article like this https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00004-3/abstract | |||
:::discusses one of the more common hypotheses, that some patients lack peripheral tissue conversion of t4 into t3. I feel something like this makes for a suitable source in context? ] (]) 13:03, 14 December 2024 (UTC) | |||
:I think that an article like this would be sufficient for paraphrasing a background section of an article, if a higher quality review/textbook etc is not available. In my own editing I would not share the hypotheses of a mechanism responsible for persisting symptoms from a commentary article without higher quality supporting MEDRS sources.] (]) 13:13, 14 December 2024 (UTC) | |||
::Thank you Jen, that makes perfect sense. ] (]) 13:17, 14 December 2024 (UTC) | |||
== Requested move at ] == | |||
{{cite journal | last=Chen | first=YP | last2=Liaw | first2=LL | last3=Wang | first3=CL | last4=Chen | first4=IC | last5=Wu | first5=WJ | last6=Wu | first6=MD | last7=Yuan | first7=GF | last8= | first8= | title=Cloning and characterization of monacolin K biosynthetic gene cluster from Monascus pilosus. | journal=Journal of agricultural and food chemistry | volume=56 | issue=14 | pages=5639-46 | date=23-Jul-2008 | year=2008 | url=http://www.ncbi.nlm.nih.gov/pubmed/18578535 | pmid=18578535 | doi=10.1021/jf800595k | pmc=10.1021/jf800595k }} | |||
] There is a requested move discussion at ] that may be of interest to members of this WikiProject. '']''<sup>]</sup> 14:24, 15 December 2024 (UTC) | |||
:The proposal is to move the page ] → ]. ] (]) 19:42, 16 December 2024 (UTC) | |||
{{cite journal | last=Lee | first=CL | last2=Pan | first2=TM | last3= | first3= | title=Red mold rice extract represses amyloid beta peptide-induced neurotoxicity via potent synergism of anti-inflammatory and antioxidative effect. | journal=Applied microbiology and biotechnology | volume=79 | issue=5 | pages=829-41 | date=Jul-2008 | year=2008 | url=http://www.ncbi.nlm.nih.gov/pubmed/18438657 | pmid=18438657 | doi=10.1007/s00253-008-1480-8 | pmc=10.1007/s00253-008-1480-8 }} | |||
== PANDAS == | |||
{{cite journal | last=Lee | first=CL | last2=Wang | first2=JJ | last3=Pan | first3=TM | last4= | first4= | title=A simple and rapid approach for removing citrinin while retaining monacolin K in red mold rice. | journal=Journal of agricultural and food chemistry | volume=55 | issue=26 | pages=11101-8 | date=26-Dec-2007 | year=2007 | url=http://www.ncbi.nlm.nih.gov/pubmed/18047280 | pmid=18047280 | doi=10.1021/jf071640p | pmc=10.1021/jf071640p }} | |||
There are a lot of new SPAs at ]; more eyes needed. ] (]) 09:38, 16 December 2024 (UTC) | |||
:Could some people please put this article on their ]? In the last month, only nine registered editors with this on their watchlists have checked this article. ] (]) 19:42, 16 December 2024 (UTC) | |||
{{cite journal | last=Wang | first=TH | last2= | first2= | title=Monascus rice products. | journal=Advances in food and nutrition research | volume=53 | issue= | pages=123-59 | date=2007 | year=2007 | url=http://www.ncbi.nlm.nih.gov/pubmed/17900498 | pmid=17900498 | doi=10.1016/S1043-4526(07)53004-4 | pmc=10.1016/S1043-4526(07)53004-4 }} | |||
:I added it to my watchlist. Is the article itself getting vandalized? If so it might need page protection. ]] <sup>(])</sup> 21:36, 16 December 2024 (UTC) | |||
::No, it's getting well-intentioned efforts from people who believe the article has the wrong POV. They may not be 100% wrong, so we need good editors here. ] (]) 21:45, 16 December 2024 (UTC) | |||
:::Correct; and it is a difficult topic complicated by multiple factors. The topic has long been plagued by canvassing that occurs at popular tic-related message boards and online support groups for parents -- a phenomenon mentioned in multiple sources -- so editors who understand policy and guideline as well as medicine have been lacking to keep up with that. Some dated sections need rewriting (not so much for changed content, but to update the citations used that usually say same), but motivation wanes when much educating about policies and guidelines has to be done along the way, along with answering a lot of misinformation or overinterpretation of sources. Summary: more eyes needed, still and always. ] (]) 13:43, 17 December 2024 (UTC) | |||
:::Here is a lay article that provides an overview of the territory: | |||
:::* https://www.gavi.org/vaccineswork/when-infection-sparks-obsession-pandas-and-pans | |||
:::] (]) 14:31, 17 December 2024 (UTC) | |||
A good deal of the talk discussion at PANDAS is now about PANS, which was AFD'd 12 years ago (]). Is it time now to create that article? When PANS first came up, it was just another in a string of hypotheses (PANDAS, PITANDs, PANS, CANS); now it seems to be the prevailing one. I'm unsure of the technicalities of overriding that AFD, or even if that's the best course of action; if someone clues me in on how to proceed here, I could stub up the new PANS article. {{u|Ajpolino}}? ] (]) 21:11, 17 December 2024 (UTC) | |||
{{cite journal | last=Suh | first=SH | last2=Mah | first2=JH | last3=Lee | first3=W | last4=Byun | first4=MW | last5=Hwang | first5=HJ | last6= | first6= | title=Optimization of production of monacolin K from gamma-irradiated Monascus mutant by use of response surface methodology. | journal=Journal of medicinal food | volume=10 | issue=3 | pages=408-15 | date=Sep-2007 | year=2007 | url=http://www.ncbi.nlm.nih.gov/pubmed/17887933 | pmid=17887933 | doi=10.1089/jmf.2006.097 | pmc=10.1089/jmf.2006.097 }} | |||
:I think that would be reasonable, but step one is going to be finding some good sources. ] (]) 23:17, 17 December 2024 (UTC) | |||
{{cite journal | last=Hong | first=MY | last2=Zhang | first2=Y | last3=Heber | first3=D | last4= | first4= | title=Anticancer effects of Chinese red yeast rice versus monacolin K alone on colon cancer cells. | journal=The Journal of nutritional biochemistry | volume=19 | issue=7 | pages=448-58 | date=Jul-2008 | year=2008 | url=http://www.ncbi.nlm.nih.gov/pubmed/17869085 | pmid=17869085 | doi=10.1016/j.jnutbio.2007.05.012 | pmc=10.1016/j.jnutbio.2007.05.012 }} | |||
::Secondary reviews since the 2012 AFD, at least: | |||
::# {{PMID|39334578}} 2024 | |||
::# {{PMID|34197525}} 2021 | |||
::# {{PMID|33041996}} 2020 | |||
::# {{PMID|32206586}} 2020 | |||
::# {{PMID|31111754}} 2019 | |||
::# {{PMID|30996598}} 2019 | |||
::# {{PMID|29309797}} 2018 | |||
::... at least. So if someone advises on the process for overwriting an AFD'd article, I can separate out the relevant content. ] (]) 02:16, 18 December 2024 (UTC) | |||
:::At this point, I think that just boldly replacing the redirect with a decent article would be fine. It might be convenient to draft it in your sandbox, so you can replace it in a single edit. ] (]) 06:53, 18 December 2024 (UTC) | |||
::::I could do that as soon as I get a free moment; I just wanted to be sure a bold replacement over a previous AFD wouldn't be problematic. I should be able to get to that later today, unless someone tells me doing so is unwise. ] (]) 15:31, 18 December 2024 (UTC) | |||
:::::We could take it to ] if you'd like to avoid any possible risk of a {{tl|db-repost}} complaint. (I could take it there for you, if you'd like.) ] (]) 17:19, 18 December 2024 (UTC) | |||
::::::I am drowning IRL ... maybe we could wait 'til after Christmas? I'm not sure anyone would object to the article being recreated, as I was the only one opining in the past! Whatever you think, I'm just SO out of time ... ] (]) 23:09, 18 December 2024 (UTC) | |||
:::::::]. In the meantime, here's a virtual life preserver: 🛟 ] (]) 00:06, 19 December 2024 (UTC) | |||
::::::::I don't think we need a second article. A google shows most coverage is on PANS/PANDAS together. If PANDAS is a subset of PANS then what is needed perhaps is to move the existing PANDAS article to PANS and cover PANDAS within that. That allows us to use sources talking about "PANS/PANDAS" together but also sources covering just one where appropriate. -- ]°] 10:02, 19 December 2024 (UTC) | |||
:::::::::I can't think of any reason to oppose that; would like to see more feedback, though. ] (]) 12:57, 19 December 2024 (UTC) | |||
Re {{tq|Is the article itself getting vandalized?}}, another question is whether the talk page is being used appropriately or disruptively? ] (]) 22:36, 23 December 2024 (UTC) | |||
== ] == | |||
{{cite journal | last=Lee | first=CL | last2=Wang | first2=JJ | last3=Pan | first3=TM | last4= | first4= | title=Red mold dioscorea has greater hypolipidemic and antiatherosclerotic effect than traditional red mold rice and unfermented dioscorea in hamsters. | journal=Journal of agricultural and food chemistry | volume=55 | issue=17 | pages=7162-9 | date=22-Aug-2007 | year=2007 | url=http://www.ncbi.nlm.nih.gov/pubmed/17655247 | pmid=17655247 | doi=10.1021/jf071293j | pmc=10.1021/jf071293j }} | |||
If someone has an or two eyes on that - new account promotes findings of a review regarding associations of IQ and fluoridation (what is missing: decrease in IQ points). This review is flawed - ] - as it solely relies on the flawed papers from the past. --] (]) 18:54, 19 December 2024 (UTC) | |||
:Thanks for the note. | |||
{{cite journal | last=Lee | first=CL | last2=Wang | first2=JJ | last3=Pan | first3=TM | last4= | first4= | title=Improving the ratio of monacolin K to citrinin production of Monascus purpureus NTU 568 under dioscorea medium through the mediation of pH value and ethanol addition. | journal=Journal of agricultural and food chemistry | volume=55 | issue=16 | pages=6493-502 | date=8-Aug-2007 | year=2007 | url=http://www.ncbi.nlm.nih.gov/pubmed/17636932 | pmid=17636932 | doi=10.1021/jf0711946 | pmc=10.1021/jf0711946 }} | |||
:This is a political 'thing' in the US at the moment, so having a decent article will be the best way to prevent well-intentioned but imperfect attempts to improve it. In particular, I think that the claims that have been in the news for the last year should be directly mentioned and addressed. Usually, if we put in something that says "____ was claimed, but this is wrong because..." then that will work, but if we remove it, then people assume that it's accidentally missing, and that we would consider if helpful for someone to add "____ is true!" to the article. ] (]) 21:45, 19 December 2024 (UTC) | |||
:: That ist true, but the SPA is now even removing all criticism at all. I didn't delete it just moved it. | |||
:: that is why this is highly flawed and needs attention by more members here. The SPA is just reverting in a nonconstructive way.--] (]) 22:13, 19 December 2024 (UTC) | |||
:@], I see you were editing that page recently. @] semi'd the page indefinitely years ago. What do you think about raising that to ]? Or tagging it as part of ], since that's what's driving the edit wars? ] (]) 00:18, 20 December 2024 (UTC) | |||
::Better sooner than later. | |||
:: You see that also on the discussion page. --] (]) 17:49, 20 December 2024 (UTC) | |||
== Review AI-generated articles == | |||
{{cite journal | last=Xie | first=X | last2=Tang | first2=Y | last3= | first3= | title=Improving simvastatin bioconversion in Escherichia coli by deletion of bioH. | journal=Metabolic engineering | volume=9 | issue=4 | pages=379-86 | date=Jul-2007 | year=2007 | url=http://www.ncbi.nlm.nih.gov/pubmed/17625941 | pmid=17625941 | doi=10.1016/j.ymben.2007.05.006 | pmc=10.1016/j.ymben.2007.05.006 }} | |||
Hi there! While reviewing at AfC, I recently came across several AI-generated medical articles, some of which are still in draftspace and some of which have been accepted and moved to mainspace. These articles do not immediately come across as AI-generated, but when run through , they have high AI-generation scores. | |||
{{cite journal | last=Xie | first=X | last2= | first2= | title=Efficient synthesis of simvastatin by use of whole-cell biocatalysis. | journal=Applied and environmental microbiology | volume=73 | issue=7 | pages=2054-60 | date=Apr-2007 | year=2007 | url=http://www.ncbi.nlm.nih.gov/pubmed/17277201 | pmid=17277201 | doi=10.1128/AEM.02820-06 | pmc=10.1128/AEM.02820-06 }} | |||
* ] | |||
* ] | |||
* ] | |||
* ] | |||
* ] | |||
* ] | |||
I would really appreciate it someone over here could help go through the articles to ensure accuracy. Thank you! ] (]) 16:42, 22 December 2024 (UTC) | |||
:@], I looked at ]. It was created in multiple edits over the space of several hours. All the refs are real. (I know nothing about the subject matter.) Do you have any reason except for the tool to believe that this is LLM content? | |||
:I am suspicious of "detector" tools, because they ] declare content that I wrote to be generated by an LLM. ] (]) 22:55, 22 December 2024 (UTC) | |||
::Hi, ]! I ran it through . That particular article shows a 99.8% AI-generation score. ] (]) 03:01, 23 December 2024 (UTC) | |||
:::@], I ran some of through the same tool, and it said human: 0.983, ai: 0.017, and mixed: 0.0. Try putting in the tool and see what you get. ] (]) 05:48, 23 December 2024 (UTC) | |||
::::]: Interesting... I'll have to bring this up to the individual who created the tool. I initially ran the edit before mine through the tool, and it told me 90-100% AI-generated. ] (]) 01:15, 24 December 2024 (UTC) | |||
:::::Although the tool may be wrong, I do find it telling that when I ask ChatGPT to write a Misplaced Pages article about Bile acid synthesis disorders, it basically writes the exact article currently published. | |||
:::::Chat's lead reads, "Bile acid synthesis disorders (BASDs) are a group of rare, inherited metabolic conditions caused by defects in the enzymes involved in the production of bile acids. Bile acids are essential for the digestion and absorption of fats and fat-soluble vitamins, as well as for the regulation of cholesterol levels. BASDs can lead to a variety of symptoms, including liver dysfunction, malabsorption, and developmental delays." | |||
:::::Aside from a few slight wording adjustments, this is exactly what is written in the article. The classification section is the same way. The other sections have similar starts. Chat's sections are just about a sentence each, so it's quite possible each section was started and then asked something along the lines of "Could you expand on that"? When I asked GPT to expand on classification, it started adding similar information as to what is in the article. ] (]) 01:26, 24 December 2024 (UTC) | |||
::::::I wonder if it is (now) adapting the Misplaced Pages article, or if it would have given you the same results before the Misplaced Pages article was created. ] (]) 01:41, 24 December 2024 (UTC) | |||
== No CSD for badly referenced medical articles/gibberish? == | |||
] (]) 02:09, 13 January 2010 (UTC) | |||
So, ] has sadly been created by one of my students (sorry). But it also made me suprised - I was going to CSD it but I could not see an applicable criterion? <sub style="border:1px solid #228B22;padding:1px;">]|]</sub> 11:53, 23 December 2024 (UTC) | |||
:Nerd I think that if you added a basic GUI to it and perhaps also some options eg restricting searches to a range of years and so forth it could become quite a popular tool. I have added it to my userpage though for when it comes in handy.--] | ] 22:45, 14 January 2010 (UTC) | |||
:One person's "badly referenced medical content" is another person's ]. I think you did a reasonable thing by moving it to the Draft: namespace. ] (]) 19:23, 23 December 2024 (UTC) | |||
== ] == | |||
::This is not the sort of thing that I would think would have a CSD criterion at all. ] ] 19:50, 23 December 2024 (UTC) | |||
:::I agree. It's not concrete and indisputable enough. ] (]) 20:43, 23 December 2024 (UTC) | |||
== Clean up of Thyroid hormone articles == | |||
..needs a few eyes. It has accumulated vandalcruft and spam. Now semi-protected for a while.] <small>]</small> 05:12, 13 January 2010 (UTC) | |||
Hi Wikiproject Medicine, seeking a little bit of preliminary input here. | |||
::Yes agree this is a poor quality page. Not sure how to fit it in with the rest of the ] topic. The management section of obesity is well done IMO :-) but I might have a COI. Maybe redirect intentional weight loss to the management section of obesity and change the name of the page to unintentional weight loss? This would reduce duplication of content. ] (] · ] · ]) 22:50, 14 January 2010 (UTC) | |||
I'm looking at how WP presents information around Thyroxine, Levothyroxine, Levothyroxine Sodium; and Tri-iodothyronine, Liothyronine and Liothyronine Sodium. Thinking a bit about the best way to present the info, because I know how interchangably some of these terms get used even in literature (eg liothyronine used to refer to endogenous tri-iodothyronine, or levothyroxine sodium being commonly referred to as levothyroxine), even though they technically refer to different things. | |||
== Surgery task force == | |||
At the moment: | |||
I proposed the surgery task force ]. I thought that I might bring it up here to stir up some interest. Surgery is a vast branch of medicine that requires comprehensive coverage on Misplaced Pages. If interested, add your self to the list ]. Thanks. ] <font color="#960018"></font> <small></font>]]</small> 01:18, 14 January 2010 (UTC) | |||
For T<sub>3</sub>, there's a page for Liothyronine the drug, and one for Tri-iodothyronine the hormone. | |||
== A new ambitious user == | |||
For T<sub>4</sub>, there's one page called Levothyroxine which is for the drug, and another page called Thyroid Hormones for Thyroxine the hormone (but this page covers both T<sub>4</sub> and T<sub>3</sub>). | |||
User:Immunize (]) has been creating new unreferenced medical articles and has been making unreferenced additions to existing medical articles. I have been trying to get this user to ], but he is reluctant to take my advice. Also, the user's grammar and punctuation need help. I simply cannot keep up with this user's edits and I also am nowhere near an expert in the topics in which he is contributing. Can someone take a look at this person's edits? Regards, ] (]) 15:11, 14 January 2010 (UTC) | |||
For consistency, I'm trying to decide if it would be of benefit to: | |||
::Yes looks like he / she could be a very good contributor if he / she referenced what they wrote. Will look into it.] (] · ] · ]) 22:42, 14 January 2010 (UTC) | |||
:::It looks like the contributor's work comes from . Is that a reliable source? It looks like the articles there are written by MDs or PhDs and sources are cited. ] (]) 22:51, 14 January 2010 (UTC) | |||
::::It is sort of reliable but is not a preferred reference source. But to reference the actual research / review or a more stable source such as a text book.] (] · ] · ]) 22:53, 14 January 2010 (UTC) | |||
:::::]. ---] (]) 23:17, 14 January 2010 (UTC) | |||
::::::I do not see were it says this? ] (] · ] · ]) 23:21, 14 January 2010 (UTC) | |||
:::::::I was being facetious. Sorry... ---] (]) 00:16, 15 January 2010 (UTC) | |||
:::::Well I cited Emedicine in a few of Immunize's articles, as it is better than nothing. I found a couple of primary articles and reviews, but most were in journals my University did not have an online subscription to, so I figured it was better off left to someone who can read them deal with. Thanks, ] (]) 23:24, 14 January 2010 (UTC) | |||
:I'm still cleaning up a lot of this user's issues. He doesn't really listen to my warnings very well. Can someone else please give him some advice? I fear this may end up on ANI if it doesn't get better. ] (]) 16:32, 15 January 2010 (UTC) | |||
A) propose a merger of Tri-iodothyronine into Thyroid Hormones (with the result being three pages -- one for thyroid hormones, one for liothyronine the drug, one for levothyroxine the drug) | |||
== GA reviews == | |||
B) propose that Thyroxine the hormone gets its own article and the Levothyroxine page becomes more exclusively about the drug (with the result being five pages, one overview of thyroid hormones, one for thyroxine the hormone, one for levothyroxine the drug, one for tri-iodothyronine the hormone, one for liothyronine the drug). | |||
I am currently doing two GA reviews in which editors have requested further opinions. Wondering if someone could take a look at ] and ] and give us your opinions? ] (] · ] · ]) 19:21, 14 January 2010 (UTC) | |||
Thoughts? ] (]) 00:55, 26 December 2024 (UTC) | |||
== HNPCC/Lynch syndrome == | |||
:thank you for post--] (]) 00:23, 31 December 2024 (UTC) | |||
: When a substance is both a natural hormone and a drug, generally there are separate articles. For example ] vs. ], ] vs. ]. So I would support having separate hormone and drug articles for T<sub>3</sub> and T<sub>4</sub>. | |||
: ] (T<sub>4</sub>; the natural hormone) was once a standalone article that was turned into a redirect to ] (the synthetic drug). Thyroxine (and also levothyroxine) refers specifically to T<sub>4</sub>. ] refers to thyroxine and its active metabolites (T<sub>3</sub>, rT<sub>3</sub>, etc.) | |||
: There are three somewhat overlapping topics here: the chemical substances, the hormone(s), and the drug that fall under the scope of ], ], and ] respectively. The is a general rule in ], one article for each chemical substance. Hence we should have separate articles for T<sub>4</sub>, T<sub>3</sub>, rT<sub>3</sub>, etc. that transclude {{tl|Chembox}}. Finally within the scope of ], a single article about the ] makes sense. ] (]) 11:19, 31 December 2024 (UTC) | |||
::Thank you, that makes sense. ] (]) 21:22, 31 December 2024 (UTC) | |||
: {{ping|Daphne Morrow}} The new thyroxine page could look something like ] (please especially note the hat note). ] (]) 12:21, 31 December 2024 (UTC) | |||
::Amazing, I would support this for the new thyroxine page. | |||
::I have a further question, do you think we need to be clearer on the pages about Levothyroxine and Liothyronine about the difference between plain levothyroxine and levothyroxine] sodium, plain liothyronine and liothyronine sodium? ] (]) 21:29, 31 December 2024 (UTC) | |||
::: It appears commercial formulations of both ] and ] almost always contain the sodium salt. This could be mentioned in an "available forms" section under "medical uses" (see ]). In addition, it could be mentioned that available forms include oral tablets, oral capsules, oral solution, and injectable forms. ] (]) 12:54, 1 January 2025 (UTC) | |||
::::I'm not sure that these details (e.g., tablets vs capsules) are important. I'd only include available forms if it's a bit unusual (e.g., IV-only antibiotics, since people expect those to be pills, or oral chemotherapy drugs, since people expect those to be infusions) or if there is something special to be said about a particular formulation. ] (]) 00:45, 2 January 2025 (UTC) | |||
:::::Did a quick look at sources and this is what I found: | |||
:::::'''For levothyroxine sodium:''' | |||
:::::IV is used for extreme thyroid hormone deficiency: https://www.aafp.org/pubs/afp/issues/2000/1201/p2485.html | |||
:::::Oral solution is proposed to have benefits for children and people who find it difficult to swallow tablets (https://www.nhs.uk/medicines/levothyroxine/), may be taken with some substances that usually interfere with levothyroxine in tablet form (https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1080108/full), and may allow more precise dosing (Seen this multiple times in unreliable sources but need to find a reliable source that says it). | |||
:::::'''For liothyronine sodium:''' | |||
:::::IV is ''sometimes'' used for extreme thyroid hormone deficiency (https://www.sciencedirect.com/science/article/pii/S2214624521000186) | |||
:::::Oral solution is presumably useful for children and people who have difficulty swallowing, but I didn’t find sources that back that up, so I will leave that out pending future info. Liquid may allow more precise dosing: (https://www.jstage.jst.go.jp/article/endocrj/63/6/63_EJ16-0040/_article). | |||
:::::I think it would be good to note slow-release and regular release formulations as regular release creates peaks of T3 that make it difficult to monitor and are unlike the stability of endogenous T3 levels. “slow-release oral form of liothyronine showed a delayed, smaller serum T3 peak when compared with levothyroxine plus the standard liothyronine preparation.” (https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00004-3/abstract<nowiki/>) | |||
:::::I'd like some guidance on whether details like this are good to include. ] (]) 05:32, 2 January 2025 (UTC) | |||
:::::: If a pharmaceutical company took the trouble of developing and distributing a new dosage form, this implies there is a medical need for it. As long as there is a reliable source that documents a use case for a particular dosage form, I think it is fair game for an "available forms" section. This is precisely what this section is for. ] (]) 10:26, 2 January 2025 (UTC) | |||
::::Thank you again for your help. | |||
::::Further to the question about the regular vs salt forms of levothyroxine and liothyronine, the information in the drugbox is inconsistent (eg. the image for levothyroxine shows the regular form, the image for liothyronine shows the salt form; the CAS for liothyronine goes to C15H12I3NO4, the pubchem link goes to C15H13I3NNaO5). Should I try to standardise these and if so, should I try to make all the information about the regular form or the salt form? ] (]) 11:07, 2 January 2025 (UTC) | |||
::::: My preference would be to standardize structures in {{tl|Infobox drug}} on the parent and not salt forms. Per ], drug articles should be named after the INN. In turn: {{Blockquote | |||
|text=An INN is usually designated for the active part of the molecule only, to avoid the multiplication of entries in cases where several salts, esters, etc. are actually used.|title=""|source=''Health products policy and standards''|author=World Health Organization}} ] (]) 19:03, 2 January 2025 (UTC) | |||
::::::Thank you that makes perfect sense. I’ll put cleaning up the box info on my todo list. | |||
::::::Are you intending to publish Thyroxine? Is there anything I should do to help? ] (]) 19:57, 2 January 2025 (UTC) | |||
:::::::{{done}}. ] (]) 11:19, 5 January 2025 (UTC) | |||
::::::::You’re the best, thank you so much for this. ] (]) 11:24, 5 January 2025 (UTC) | |||
== Need help on adding content to WikiProject Medicine == | |||
The ] talk page has a move dicussion on it that seems to have gone dead. I was thinking about doing some histology work on the article and found this long discussion about the relative merits of calling the page Lynch Syndrome, versus HNPCC. I found this article, , which is a recent review and recommends that there is supprt for calling the condition LS in favour of HNPCC. Is anyone still interested in this move discussion? ]]] 01:32, 15 January 2010 (UTC) | |||
Hello all. I specialize in the field of medicine and wanted to add content to wiki project medicine. However, I am very new to Misplaced Pages editing. Some hours back, I created a page on Wiki project ]]. But I can't figure out what to do now. Nor can I see my name in participants' full list. Can someone tell me If by mistake I created a wrong page? Or may be suggest me how I can actively participate, if this is the right page. Kindly help. Thanks. ] (]) 13:47, 26 December 2024 (UTC) | |||
== red hot chili pepprs, alt/compl/herbal labels == | |||
:@], welcome! The bot adds names once a day to ]. Your name is there now, so you must have done everything right. | |||
I guess this is why I hesitate to dismiss or trivialize herbal or folk lore stuff until better evidence is in. | |||
:One project underway is to get at least one reference in every article this group supports. We ]. If you want to pick one (or a dozen!) from this list and add a suitable reliable source to it, that would be really helpful. (It's even more helpful if you also remove the <code><nowiki>{{</nowiki>]<nowiki>|date=January 2010}}</nowiki></code> tag from the top of the article.) | |||
http://www.nature.com/onc/journal/v29/n2/abs/onc2009335a.html | |||
:Alternatively, if you want to work on creating a new article, look at the two sections following this. I'm sure they would appreciate some help. ] (]) 01:18, 28 December 2024 (UTC) | |||
"Capsaicin (trans-8-methyl-N-vanillyl-6-nonenamide) is an ingredient of chili peppers with inhibitory effects against cancer cells of different origin." | |||
::{{reply to|WhatamIdoing}} Thanks very much sir. Everything is appearing so new to me. As you can understand from my edits, I am very new to Misplaced Pages editing. Let me get used to this new interface. I will most definitely do as suggested. Many thanks for this huge favor.] (]) 06:32, 28 December 2024 (UTC) | |||
I think there can be a tendency here to put science into box somewhere but careful observation anywhere can be important. Personally, it wouldn't surprise me if you may be able to take peppers, garlic, and citric acid and make therapaeutic food ( if you can get ph up was per the "alkaline diet" folks). Citric acid would be interesting as that is a case where ( possible, if recent conjecture is right ) that folk lore about fruit juice could turn out to be right but in fact everyone was distracted by the anti-oxidants ( ascorbic acid). | |||
:::We're always glad to see new people helping out. | |||
] (]) 15:10, 15 January 2010 (UTC) | |||
:::BTW, for adding sources to articles, I prefer using the visual editor. You should use whichever you like best. So you can compare them, for the article ], here's a link that will take you straight to and here's a link that will give you the same article . ] (]) 01:47, 29 December 2024 (UTC) | |||
:I just wanted to echo user WAID's warm welcome. It is great to see new medical editors here! Happy editing and feel free to reach out anytime if you have any questions or want us to take a peek at your edits as you learn. ] (]) 02:41, 1 January 2025 (UTC) | |||
== New drug names == | |||
::You need a prescription for this stuff in Canada. I prescribe a cream of it frequently. Would not call it folk lore as it use is based on randomized trials and is an integral part of medicine. ASA comes from the willow tree but a cardiologist is not the same as a naturalpath. | |||
::The research you provide appears to be done by physicians / medical researchers which makes it medicine. Also it has in no way reached clinical utility.] (] · ] · ]) 17:40, 15 January 2010 (UTC) | |||
::: I'm big on MOA and background myself but in terms of describing what is thought to work, there seems to be a tendency to ignore anything that doesn't come along with credentials. OF course, we need well controlled test and MOA but that doesn't mean that anecdotes would mislead the reader about state of human understanding or what may really work. If you were a PhD looking for leads, sometimes talking to a Shaman can be helpful for ideas even if his thoughts don't prove to be right or systematic. ] (]) 17:50, 15 January 2010 (UTC) | |||
::::Stuff like this might belong under a section on research but no were else in the article. And definitely not in a treatment / management section. What is MOA by the way? ] (] · ] · ]) 19:34, 15 January 2010 (UTC) | |||
:::], out of scope, see ]. MOA is mode of action. ] (]) 19:43, 15 January 2010 (UTC) | |||
:: Wiki is not a how-to self medicate publication, there is no treatment recommendation section. But, if you are describing what is thought in various communities and feel like you want to inflict good intentions on the article to save the reader, I'm just suggesting that you calm down a bit. In terms of merit, when the jury is out all you know is that it is out. If you try to leave stuff out, it is unlikely that will help people who only know about things from Suzanne Summers and Oprah. Do you want people listening to Oprah or do you at least want to present all views, including research literature, and put them into a complete context? Imagine someone coming here and finding, "gee, wikipedia didn't even know that oprah covered this in great detail." ] (]) 19:58, 15 January 2010 (UTC) | |||
Lists of new generic drug names under consideration or recommended as ]s can be found at https://www.who.int/teams/health-product-and-policy-standards/inn/inn-lists Similarly, drug names under consideration as ]s can be seen at https://www.ama-assn.org/about/united-states-adopted-names/usan-drug-names-under-consideration In the case of some new drugs, there may not be enough published information to allow an article to be written, but for others, creating an article may be possible. <span style="font-family: Times;">] (] • ])</span> 00:12, 27 December 2024 (UTC) | |||
:::No, not really: I don't generally want early research work represented in disease articles. ] stuff is generally not ], even if Oprah talked about it. I also don't want religious views on to be added to ], or common views about women's driving skills to be added to ], or popular superstitions about walking underneath ladders to be added to ]. If, on the other hand, you can get me a good source about what ''is'' on the Moon, or a good study about how gender differences affect accident rates, or how often ladder-related accidents happen, then I'm all for it. That's encyclopedic information; what inexpert or uneducated people believe is not. | |||
:::Our general rule of thumb is that if you don't have actual human trials, then it's not worth mentioning, and if it's a future regulated therapeutic, we'd rather wait until it's in Phase III trials, not merely first-in-human tests. (Note, please that this rule of thumb is biased ''against'' pharmaceutical companies.) There might be exceptions (e.g., an article about "Research on ____" might take a more expansive approach), but I'm quite satisfied with our general rule of thumb. ] (]) 06:37, 16 January 2010 (UTC) | |||
:::: The inclusion of material would depend on the topic but ignoring research or Oprah on many diseases would limit the scope of the article to an arbitrarily chosen community and not reflect what is generally known or thought. It is not crysal balling to say that " a lot of work is being done on various natually occuring products" or undue weight to mention that "many popular folk rememdies have been promoted" etc. An isolated research article may or may not merit inclusion in a given topic but I think your examples above are pushing the weight issue a bit. However, popular stories about ladder superstitions can have a place somewehere. What example of an article do you have that only mentions US FDA approved products in regards to a disease? I'm not even sure how you could possible write an article like this where there is both ongoing research and a history of folk rememdies. ] (]) 13:21, 16 January 2010 (UTC) | |||
:::::If it is well referenced ( ie nature ) adding it to a section on research may be important. What people do use a natural products may fit under the section on society and culture if appropriately worded. Added to a section on treatment is not appropriate. What sources is required depends on were it is going. Beliefs on stars is trivia and may belong on their own pages but not a on medical page.] (] · ] · ]) 21:28, 16 January 2010 (UTC) | |||
:@], in my experience, by the time a drug candidate has reached Phase 3 clinical trials, there's plenty of sources for it, and there are frequently enough sources by Phase 2. One of the challenges has been figuring out which names are the same. We'll find a paper about "ABC-1234", and then the little biotech company gets bought, and it becomes "BIG-1234", and then it gets a brand name and a generic name, and now we have to search under multiple names. | |||
::::::Um, NSB, I did not say anything about "US FDA approved products". In fact, I explicitly named standards that are (1) independent of government approval and (2) always happen before government approval and (3) can be applied just as well to a natural product as to a regulated therapeutic. Perhaps you are not very familiar with the drug approval process? ] (]) 22:18, 16 January 2010 (UTC) | |||
:For example, the first one in is https://pubchem.ncbi.nlm.nih.gov/compound/Abenacianine, aka abenacianinum, aka VGT-309. Misplaced Pages should have an article on ], or at least an article on ] with redirects from all the names. Since the biomedical sources for pre-approval drugs tend to be ], and almost always affiliated with the company (), the Misplaced Pages articles are often written more from the "business" than the "medical" side: They had these activities, they got this much money invested. | |||
::::::: Generally negative results can be hard to dig up, depending on who sponsored the trial, and there have been attempts to make negative clinical trials better known but within this communityy of scientists, there is different treatment of data yoy like and don't like. The clinical trials you mention themselves are usually govt approved trials or did you mean trials suzanne somers did? Generally there is more weight on trials leading to approval unless someone benefits from advertising a given failure. My original point in posting this link is to calm down the militant folks who want to protect people from information. If nothing else, anecdotes and folk lore can eventuall be tested and making a reader aware of prominent folk lore can help him get a better idea of what may motivate things he find in research etc. I'm just suggesting there is no down side to the goal of the encyuclopedia, except I guess you could call some of this clutter or trivia. Observations of the resarch community tend to be better controlled and accurate and can be intergrated into more systmatic understanding (MOA) but are just as much anecdotal as folk lore in some cases. If you take something literally approaching a militant attitude, you still want to know your enemy and if you have faith that science will prevail, ultimately you can insert " as was shown to be danergous this folk lore is now discredited reminding people to listen to doctors "( Obviously you wouldn't reallyu editorialize like this but presumably you would convey that message to reader ) etc. ] (]) 13:48, 17 January 2010 (UTC) | |||
:Just collecting all the names into a list could be helpful. I wonder if you'd like to talk to ] about this, as they are more specialized. ] (]) 01:37, 28 December 2024 (UTC) | |||
::{{reply to|Eastmain}} Thanks sir. I am working on these suggestions. I will get back to you again, if I have any problems. I am overwhelmed at the amount of help I am getting from completely unknown persons. The only common thread between all of us appears to be "love of knowledge", and a "genuine desire to contribute". Thank you sir once again. ] (]) 06:35, 28 December 2024 (UTC) | |||
:::I'm "ma'am", rather than sir, though most of the regulars on this page are men. | |||
:::You have given me a good excuse to remind everyone how to find out. First, if you go to ] then you can set your own gender. Remember that changing your prefs requires ticking/unticking the box plus scrolling down to click the blue Save button. (Actually changing your settings is optional, but I've done it, and if you look at the page, then the next step will make a little more sense. Whatever you choose for gender settings will be publicly visible.) | |||
:::Second, go to ] and find "Navigation Popups". This replaces the usual box when you hover over a link with a more feature-filled one. If you turn on ] and ►reload this page (don't just use the back button on your browser for the first try), then when you hover over anyone's user name, you'll see the person's gender (if any is set in preferences; blank is the default of ]), user rights/whether they're an admin, how long they've been editing, and how many edits they've made total. | |||
:::There are other ways to find out this pref setting, but I usually find that this one is the most convenient for me. ] (]) 23:03, 30 December 2024 (UTC) | |||
:: Good catch WAID. I missed that ] is the same as ]. Abenacianine is the English INN, abenacianinum is Latin, and Misplaced Pages drug articles should be named after the English INN. I renamed VGT-309 as Abenacianine and added VGT-309 as a synonym to the drug infobox. ] (]) 10:50, 29 December 2024 (UTC) | |||
== ] == | == ] == | ||
I was just working on an article about a state supreme court justice who died of complications from mandibular cancer, also known as cancer of the lower jaw, and was shocked to find that there is a rather prominent form of cancer for which we have no article. I know nothing about the topic, but perhaps someone who does have knowledge of this might write about it. ] ] 22:17, 27 December 2024 (UTC) | |||
I've decided to try to improve this article to at least a B or possibly GA. I think the main things that need improving are: history section, including past epidemics as well as cases in developing countries today; separate pathophysiology section - no real information about transmission now either; prevention, including vaccination (and possibly problems with supply in developing world); more sources needed; more distinction required between amoebic and bacillary; and an image, possibly one of the bacterium. | |||
:], are you still looking for articles your students could create? | |||
The reason I came here is because I know almost nothing about the disease, and everything I put in will be purely from what papers etc I can find. I don't think it's worth starting a PR on this now, so if anyone has any other suggestions, please make them known. I might not be able to do much next week though (so don't think I've forgotten if not much happens). ] (]) 16:18, 15 January 2010 (UTC) | |||
:I see that ] redirects to ]. ] is a red link. I'm not sure if these are treated exactly the same, but I'd assume that mandibular cancer is a subtype of oral cancer. ] (]) 01:45, 28 December 2024 (UTC) | |||
::Hello | |||
::Yes things kick off for us in the new semester starting in January so you will be hearing more from me. I will take note of this. Thank you ] (]) 13:05, 29 December 2024 (UTC) | |||
::And please do pass on other cases like this if they emerge ] (]) 13:08, 29 December 2024 (UTC) | |||
:::@], maybe also add ] to your list. We have a section at ], but it cites sources from the previous century. It was in the news a while ago, with evidence of a connection to West African ancestry. ] (]) 05:30, 30 December 2024 (UTC) | |||
::As far as I understand, cancer of the mandible would ''not'' be classified as a type of ] or even ]. ] generally refers to squamous cell carcinoma (a soft tissue cancer arising in the epithelial layer). As for cancer arising in the hard tissue of the jaw, I don't know exactly how they would be classified... maybe redirect to ] is best for now. | |||
::As the current article for ] states: "Other cancers can occur in the mouth (such as ], ], or ] from distant sites) but are also considered separately from oral cancers." | |||
::Also I don't know if there is a need for a dedicated article for each bone in terms of cancer. That is because I guess each article would be quite similar when it comes to the list of possible cancers which may originate or spread to that bone. The mandible is however possibly an exception because of the existence of that group of cancers related to the tissues which form the teeth (see ]). ] (]) 10:18, 7 January 2025 (UTC) | |||
:::Another quick note: as far as I am aware, cancer originating in the hard tissues of the jaw is significantly less prominent compared to ] of the soft tissues. I don't think it is the case that the encyclopedia is missing some very important category of cancer here. ] (]) 10:22, 7 January 2025 (UTC) | |||
== DSM copyright warnings == | |||
== Article structure for pages pertaining to symptoms == | |||
I have created {{Tl|DSM copyright}}. It's a message for talk pages, to warn editors that they can't copy the full criteria out of the ] for copyright reasons. | |||
We currently do not have a recommended structure for articles pertaining to symptoms. I am trying to address this and would appreciate input. ] ] (] · ] · ]) 06:04, 16 January 2010 (UTC) | |||
We've known about this problem ], but there are always new editors joining, and occasionally someone will replace a description with the copyrighted text of the DSM entry. Even though they're really just trying to help, the fact is that the copyright holder could actually sue them (and would win). I'd like to give these editors the information they need to do the right thing. | |||
== Expert help needed == | |||
To save time and fingers, I'd like to ask someone at ] or ] to spam this warning onto the talk pages of all the conditions listed in ]. (Anyone can add it manually to other pages, and if there's an item in that list that doesn't have a DSM entry, then it could be manually removed as irrelevant and unnecessary in that case.) Does anyone support or oppose this? ] (]) 05:48, 28 December 2024 (UTC) | |||
Hi, please could someone comment at the following discussion | |||
]. We are in need of expert comment on the use of DALY's to produce a worldmap on the self-harm page. The main concern being that the lay person will not understand the map. Many thanks, ] (]) 07:46, 16 January 2010 (UTC) | |||
:I support ]] <sup>(])</sup> 07:42, 28 December 2024 (UTC) | |||
== ] == | |||
:Support asking a bot to place message on talk pages (I've actually had to argue this recently here on this talk page!!) ] (]) 20:35, 28 December 2024 (UTC) | |||
:I support placing message and bot publishing it to talk pages. ] (]) 00:39, 29 December 2024 (UTC) | |||
:{{reply to|WhatamIdoing}} I support it sir wholehearted. However, there could literally be thousands of pages, where one could unintentionally add a DSM category. Being a newbie, I was wondering, about the possibility of having a Bot, which could automatically warn an editor, that he was adding something that was copyrighted. This would be far simpler than somebody keeping on removing unwanted entries. Of course, I am not sure, if such a bot exists, or could even be created. Kindly advise. ] (]) 06:44, 30 December 2024 (UTC) | |||
::At the moment, we can't give real-time warnings, and since not all books are digitized, it'll never be perfect. But we do have a system that runs after you've added some text, to check for probable copyvios. Because the copyvio systems are really matching to "matches this website" – and some websites aren't copyrighted – it requires manual review after that, but we think we're catching at least most of it that way. ] (]) 07:14, 30 December 2024 (UTC) | |||
:::{{reply to|WhatamIdoing}}Thanks sir for your valuable comments. Yes, "real-time warnings" are what I meant. A system checking for "copyright violations" also sounds good enough. I did find a page for copyvio template . Thanks very much. ] (]) 07:32, 30 December 2024 (UTC) | |||
::::Agreed: the book is copyrighted material. I support the tag and bot(s). ] (]) 19:27, 30 December 2024 (UTC) | |||
== Prostate cancer TFA February 4 == | |||
Someone here may want to look at that procedure, particularly if you have access to PMID 17766626. The wiki article looks a bit advertorial. Currently at AfD. ] ] 11:23, 16 January 2010 (UTC) | |||
Please watchlist the article for vandalism or inappropriate edits on February 4, when it appears on Misplaced Pages's mainpage. | |||
: Everything I need to know in life, I learned on Wiki. ] (]) 04:37, 17 January 2010 (UTC) | |||
* ] | |||
:: I cleaned it up, if others want to have a look or try to expand if you have access to the sources listed. I hope I get a barnstar-- ''or something''-- for now being the editor with the highest edit count on this topic. ] (]) 05:45, 17 January 2010 (UTC) | |||
Great work by {{u|Ajpolino}} ! ] (]) 16:53, 28 December 2024 (UTC) | |||
:: Glad to be of help :-0 ] ] 09:05, 17 January 2010 (UTC) | |||
== Fun Christmas paper == | |||
== Help with ] on Main Page tomorrow (17th Jan) == | |||
Some of you might be interested in reading this: | |||
I'd appreciate folk here adding this to their watch page and helping out with vandalism, etc. I'm going to be asleep for the initial hours of the 17th! Thanks. ]°] 17:59, 16 January 2010 (UTC) | |||
* {{Cite journal |last=Cro |first=Suzie |last2=Phillips |first2=Rachel |date=2024-12-14 |title=All I want for Christmas…is a precisely defined research question |url=https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-024-08604-w |journal=Trials |volume=25 |issue=1 |pages=784 |doi=10.1186/s13063-024-08604-w |issn=1745-6215 |pmc=PMC11645783 |pmid=39673058}} | |||
:Congratulations on the FA. The first 90 minutes were pretty quiet... I hope that the rest of the day goes as well. A new editor has asked a question on the talk page that will be easier for someone that is familiar with the named sources to answer. ] (]) 03:40, 17 January 2010 (UTC) | |||
] (]) 01:53, 29 December 2024 (UTC) | |||
==Does WP:MEDRS apply for pet studies?== | |||
:: I'm sure Colin will get to it (and the other pleasantries on the talk page) as soon as he wakes up. ] (]) 04:39, 17 January 2010 (UTC) | |||
See talk-page discussion at ], a user added a trial and it was removed by another editor. My understanding is that MEDRS does also apply for biomedical claims made about pets and that we shouldn't use primary sources such as a single feeding trial. I could be wrong though; it's been a while since I edited anything related to pets. Seeking clarification on this. ] (]) 22:33, 30 December 2024 (UTC) | |||
== ] == | |||
:As pet foods and medications are regulated by the FDA under an almost identical pathway as human drug approvals and indications, I’d agree that WP:MEDRS applies. | |||
I am intending on start a page on this topic to deal with the medical approach to violence and agitation. Wondering what term I should us for the title? Here is a paper on the topic. <ref>{{cite journal |author=Rossi J, Swan MC, Isaacs ED |title=The violent or agitated patient |journal=Emerg. Med. Clin. North Am. |volume=28 |issue=1 |pages=235–56, x |year=2010 |month=February |pmid=19945609 |doi=10.1016/j.emc.2009.10.006 |url=}}</ref> | |||
:Could you find somebody in a veterinary Project to get their impression (since that’s more into their speciality)? Thnx, again, I agree it should apply! ] (]) 22:36, 30 December 2024 (UTC) | |||
{{reflist}}] (] · ] · ]) 02:17, 17 January 2010 (UTC) | |||
::VETMED was always a small group, and I'm not sure who's around these days. | |||
::Historically, the community has been more tolerant of primary sources being cited for content that could not possibly have any human medical application. Also, ] ("Extraordinary Claims Require Extraordinary Evidence") applies to all content. If the results are surprising ("e.g., ] are healthy on a long-term vegan diet"), then I'd want more than a primary source. If the results are ] ("Mammals need to eat food"), then a peer-reviewed primary journal article (especially its background/overview section) might be a strong enough source. In between those two extremes, you'll have to use your judgment. | |||
::Sometimes the fastest solution is to find another source. ] (]) 22:50, 30 December 2024 (UTC) | |||
:::Thanks for the suggestions and I agree. Unfortunately there are hardly any studies that have been done on vegan dog diets and no good reviews. The feeding trial in question was this one . There is a serious lack of secondary sources discussing this kind of topic. I think it would be best to wait until more research has been published. I disagree with citing just one trial. We need better secondary sourcing. ] (]) 22:58, 30 December 2024 (UTC) | |||
::::And it's recent, so we're unlikely to find it in textbooks yet. It's possible that there is some sort of popular press comment on it. Those tend to be lousy sources in a different way, though, even the ones that are technically secondary sources. ] (]) 23:36, 30 December 2024 (UTC) | |||
== Request additional eyes on ] == | |||
::Would ] be better and redirect the above? I think so.] (] · ] · ]) 04:30, 17 January 2010 (UTC) | |||
::: Probably, since MEDMOS says something about "patient" vs. "individual" terminology. ] (]) 04:38, 17 January 2010 (UTC) | |||
A recent addition was made to the article. The addition doubled the text length of the article and focuses on negative aspects of the organization's lobbying (sources appear sound). It would be good to get people who are familiar with articles about professional medical organizations to look at the addition to make sure it adheres to NPOV. ] (]) 19:34, 1 January 2025 (UTC) | |||
:::"Violence (medicine)" makes me think ], e.g., how to treat survivors of violent crimes, which is not what you're aiming for. ] (]) 04:50, 17 January 2010 (UTC) | |||
:If the information from 2004, that the ASA “spent the second-largest sum of money on lobbying of all professional physician associations in the United States.” is true for the long term, then I would expect lobbying to take up a greater portion of their page than other pages about professional medical organisations. | |||
::::How about ]? A little wordy but gets the point across... ] (] · ] · ]) 05:00, 17 January 2010 (UTC) | |||
: |
:I’m concerned about the focus on recent contentious lobbying however. Sounds like the ASA been lobbying for decades with a lot of money, and if so, this section should reflect whatever those other efforts were. ] (]) 21:15, 1 January 2025 (UTC) | ||
:"In the 2000s, the ASA lobbied to force anesthesiologists to be in the hospital room whenever an anesthesia drug was administered to patients during colonoscopies " is unreferenced. NYT article does not mention it. ] (]) 21:20, 1 January 2025 (UTC) | |||
:::::: If we drop "managing", we're right back to Violence (medicine). ] (]) 05:42, 17 January 2010 (UTC) | |||
::NYT article does not mention propofol either. ] (]) 21:22, 1 January 2025 (UTC) | |||
:::This is a topic that is outside my normal area of knowledge but the new material, made the article shift from what seemed like kind of a high level, boiler plate description to something that looked like an attack article trying to pass as encyclopedic. Like I said, some level of content may make sense but not 50% of the article. I will note that a recent search for articles that mentioned the organization didn't say anything about these controversies. This suggests the material is getting too much weight. Still, I think getting more eyes on the topic would be best. ] (]) 21:42, 1 January 2025 (UTC) | |||
::Also there is lack of context, as the Tampa Bay Times article points out that the Nurse Anesthetist society spent a lot of money lobbying in opposition to the ASA. And the NYT article points out that the *third* highest spender in lobbying was the nurse anesthetist society. And there is no attention paid to the ASA's contention that their lobbying effort is to ensure patient safety. In my opinion, it reads more like an advocacy piece than an encyclopedic piece. That being said, there are some good points here- for example, pointing out the role of money and lobbying in health care in the US is very important. I think the battle between the nurse anesthetists and the anesthesiologists is noteworthy but it would need more context. ] (]) 21:43, 1 January 2025 (UTC) | |||
:Also the part about the anomalous billing does not represent fully what is stated in the references. ] (]) 21:51, 1 January 2025 (UTC) | |||
::In fact, one of the sources states "the authors have stressed that their findings should not be interpreted to indicate fraud because fraud involves intent, which could not be determined." So in my opinion, this is somewhat misrepresentating the reference. ] (]) 21:58, 1 January 2025 (UTC) | |||
== Discussion at COVID-19 Lab Leak Theory about inclusion of anti-Chinese racism in lead == | |||
] ] (]) 15:31, 2 January 2025 (UTC) | |||
::::::::] is a little different from Violence (medicine) and I agree is better.] (] · ] · ]) 05:50, 17 January 2010 (UTC) | |||
:commented--] (]) 12:54, 4 January 2025 (UTC) | |||
== rT3 and T3 testing == | |||
http://www.nice.org.uk/CG25 - this is the English/Welsh guideline for acute violence in the medical context. Hope you find it useful. ] | ] 11:21, 17 January 2010 (UTC) | |||
Hi all, | |||
== Curious.. == | |||
Does anyone know where I’d find a MEDRS source that documents whether high rT3 levels can interfere with Free T3 immunoassay and/or ultrafiltration LC-MSMS tests? | |||
..are there any lipid metabolism disorders that may present as a mild case of diabetes that is aggravated by lipid intake? Or any case of diabetes? --<font color="000066">]</font> 16:41, 17 January 2010 (UTC) | |||
All I can find is information that Free T3 immunoassays are prone to interference and that Free T3 affects rT3 radioimmunoassay tests, but no information about vice-versa. | |||
:Do we mean the same thing when we say "lipid metabolism disorder"? I think of a purely genetic problem (i.e., enzyme mutation). There are all kinds of much more common things that are "aggravated" by "lipid intake" in some people, e.g., pancreatitis, gall bladder problems, hepatitis... ] (]) 17:39, 17 January 2010 (UTC) | |||
Edit: This primary source seems concerned that rT3 and T3 could interfere with tests of each other because they are isobars of each other, but satisfied that there are methods to separate them in LC-MS/MS tests. https://link.springer.com/article/10.1007/s00216-019-01724-2 | |||
== Article needs help == | |||
I'll keep looking for more info about current immunoassays and for secondary sources. | |||
This article, ], has multiple issues I cannot find. Please leave me a talkback or reply on my page.--] ] 20:27, 17 January 2010 (UTC) | |||
] (]) 02:57, 5 January 2025 (UTC) | |||
::I recommend condensing it to one or two lines and adding it to the main ] page than putting in a redirect.] (] · ] · ]) 20:33, 17 January 2010 (UTC) | |||
:rT3 is rarely tested in clinical practice, and the utility of it outside of the context of central hypothyroidism vs euthyroid syndrome is highly debated in research. I'm not sure if or where information on this specefically could be found. ]] <sup>(])</sup> 03:32, 5 January 2025 (UTC) | |||
== Merger == | |||
::Ah yes, I had gathered this from my sources so far, it’s good to have it confirmed by others. | |||
::I was thinking maybe someone might know a pathology manual or some testing data from the original verification of the tests? ] (]) 03:47, 5 January 2025 (UTC) | |||
== Colostrum health claims NPOV concerns == | |||
As far as I am aware ] and ] are the same thing yet we have two large pages on them. Having a merge discussion here ] ] (] · ] · ]) 00:40, 18 January 2010 (UTC) | |||
The ] article seems to be NPOV and promotional. I am going to look at it. Would appreciate others as well. ] (]) 14:22, 5 January 2025 (UTC) | |||
== ] == | |||
== ] NPOV issues == | |||
I think the article should be tagged for this project. The lede seems POV in that these are largely untested and unregulated chemicals used recreationally and known to cause medical problems yet the article seems to glow about how harmless they are. Thoughts? ] 19:12, 18 January 2010 (UTC) | |||
:The article has been a cesspit for awhile. I abandoned it a year or two ago after a proliferation of warring ] depressed me. It would probably be worthwhile to revisit it. ''']''' <sup>]</sup> 21:18, 18 January 2010 (UTC) | |||
::ONe of those SPA's was, IMHO, Hank Wilson who seems to have been a lone activist trying to collect and distribute the scientific studies he found. He died last year at some point. The others have every appearance of selling the stuff. ] 03:50, 19 January 2010 (UTC) | |||
:::The recreational drug pages along with sex topics are some of Wikipedias most visited. They are also the most heavily vandalized. Both fall under WP:MED! Are we not lucky? ] (] · ] · ]) 04:38, 19 January 2010 (UTC) | |||
::::] passed away at the end of 2008, and I do remember hearing that he had held on to the causation of poppers with AIDS/KS long after that was abandoned. Here's a attributed to him. I don't see anything in the article covering poppers use and increased STD risk due to vasodilation, although there is material on tie to increased high-risk behavior and on use with Viagra. With respect to the pages popularity, I've been working under the assumption that flagged revisions would eventually wind their to way to a lot of med articles at some point for that reason. -] (]) 04:47, 19 January 2010 (UTC) | |||
As I am not an expert, I want to bring to your attention that the article ] has NPOV issues. See ]. Note also the article ] describing a related practice. ] (]) 13:43, 6 January 2025 (UTC) | |||
== ] == | |||
== Viral spread of rumour about HMPV == | |||
Can some project members review the use of medical sources in this article ? The basic issue is outlined at this ], and particularly ]. ] (]) 10:39, 19 January 2010 (UTC) | |||
There's an informal RM at ]. I suggest that people from this wikiproject add some arguments for or against the proposal to rename the article, or with specific proposals for a new name. ] (]) 15:57, 6 January 2025 (UTC) | |||
::Delete all the primary research and replace it with the one 2007 review. Add the conclusions of this review to the lead. That should correct things.] (] · ] · ]) 11:02, 19 January 2010 (UTC) | |||
== RfC about TAAR1 agonism as the mediator of amphetamine monoamine release == | |||
Partial cross posting Fringe Theories Notice Board: | |||
Hello, all. Just fyi, I received a random Rfc notification due to my signup for the ]. You can find the Rfc discussion on '''TAAR1 agonism as the mediator of amphetamine monoamine release''' ]. (This is just a notification and not an endorsement; in particular, I have not checked it for ] compliance.) Thanks, ] (]) 02:55, 7 January 2025 (UTC) | |||
:::I would remind editors here that the core policy, ] and guideline, ] favour peer reviewed studies, and these are peer reviewed studies. Second, the studies are not being used to support a claim but are examples of research on a particular topic which is the topic of the article. No editor opinion trumps a policy, and especially a core policy nor does a guideline like the fringe theories guideline supercede a core policy. Finally, I would assume that in advising deletion of all of the studies editors here will have read the studies or at least looked at the abstracts.(] (]) 14:55, 19 January 2010 (UTC)) |
Latest revision as of 10:22, 7 January 2025
Welcome to the WikiProject Medicine talk page. If you have comments or believe something can be improved, feel free to post. Also feel free to introduce yourself if you plan on becoming an active editor!
We do not provide medical advice; please see a health professional.
- Unsure about something? Make sure to look at our style and source guidelines.
- Please don't shout, remain civil, be respectful to all, and assume good faith.
- Put new text under old text. Click here to start a new topic.
- Please sign and date your posts by typing four tildes (
~~~~
). - Threads older than 30 days are automatically archived.
- Please see Misplaced Pages:WikiProject_Medicine/Newsletter/Mailing_list
List of archives | |
---|---|
|
This page has been mentioned by a media organization:
|
Delay, Deny, Defend (practice)
I recently created a draft for Delay, Deny, Defend (practice), which has recently gotten a lot of press in the aftermath of the Killing of Brian Thompson. There is currently an article for the book Delay, Deny, Defend, but I believe the practice is notable enough for its own article. I'd appreciate any help with sourcing. Thank you, Thriley (talk) 20:22, 6 December 2024 (UTC)
Images
We at Wiki Project Med Foundation are supporting an illustrator. Do folks here have drawings they wish to see created? Doc James (talk · contribs · email) 20:16, 9 December 2024 (UTC)
- In 2015, an illustrator made this diagram for us. Perhaps this will spark an idea for someone. WhatamIdoing (talk) 22:10, 9 December 2024 (UTC)
Looking for a Tuesday Challenge? Pelvis_justo_major - Giant Pelvis
Hi! I came across this article from the list of uncited articles. It has some very very very outdated citations! I looked briefly on pubmed and also did some hand searching on google for anything anywhere near a MEDRS source. I am now out of time and figured I would post it here in case someone else wants to try this challenge! Perhaps there is a more common name for this condition of a distorted pelvis that is being missed? Not sure how they got the incidence quote etc. Happy editing!
JenOttawa (talk) 13:42, 10 December 2024 (UTC)
- this is the only thing I found--Ozzie10aaaa (talk) 13:14, 11 December 2024 (UTC)
- Thanks @Ozzie10aaaa:. I found a book on amazon that was written from the Misplaced Pages article. Yikes! https://www.amazon.com.au/Pelvis-Justo-Major-Fernande-Antigone/dp/613793196X Not using this source- ha! JenOttawa (talk) 15:38, 12 December 2024 (UTC)
- yes, that happens alot,Ozzie--Ozzie10aaaa (talk) 15:49, 12 December 2024 (UTC)
- Thanks @Ozzie10aaaa:. I found a book on amazon that was written from the Misplaced Pages article. Yikes! https://www.amazon.com.au/Pelvis-Justo-Major-Fernande-Antigone/dp/613793196X Not using this source- ha! JenOttawa (talk) 15:38, 12 December 2024 (UTC)
Merge proposed for Disorders of Sex Development and Sexual Anamolies
Here's the discussion for anyone interested. Urchincrawler (talk) 16:23, 10 December 2024 (UTC)
- thanks for post--Ozzie10aaaa (talk) 13:06, 11 December 2024 (UTC)
Introducing Let's Connect
Hello everyone,
I hope that you are in good spirits. My name is Serine Ben Brahim and I am a part of the Let’s Connect working group - a team of movement contributors/organizers and liaisons for 7 regions : MENA | South Asia | East, South East Asia, Pacific | Sub-Saharan Africa | Central & Eastern Europe | Northern & Western | Latina America.
Why are we outreaching to you?
Wikimedia has 18 projects, and 17 that are solely run by the community, other than the Wikimedia Foundation. We want to hear from sister projects that some of us in the movement are not too familiar with and would like to know more about. We always want to hear from Misplaced Pages, but we also want to meet and hear from the community members in other sister projects too. We would like to hear your story and learn about the work you and your community do. You can review our past learning clinics here.
We want to invite community members who are:
- Part of an organized group, official or not
- A formally recognized affiliate or not
- An individual who will bring their knowledge back to their community
- An individual who wants to train others in their community on the learnings they received from the learning clinics.
To participate as a sharer and become a member of the Let’s Connect community you can sign up through this registration form.
Once you have registered, if you are interested, you can get to know the team via google meets or zoom to brainstorm an idea for a potential learning clinic about this project or just say hello and meet the team. Please email us at Letsconnectteam@wikimedia.org. We look forward to hearing from you :)
Many thanks and warm regards,
Let’s Connect Working Group Member
Serine Ben Brahim Serine Ben Brahim (talk) 09:14, 11 December 2024 (UTC)
Contra TAAR1 agonism as the mediator of amphetamine actions
Requesting input on this topic here at WikiProject Pharmacology. Thanks. – AlyInWikiWonderland (talk, contribs) 10:47, 13 December 2024 (UTC)
- commented--Ozzie10aaaa (talk) 13:33, 14 December 2024 (UTC)
TNIK and comparable genes with inhibitors in clinical trials
I started this discussion at Misplaced Pages talk:WikiProject Molecular Biology, and it was suggested that I inquire here. Basically, Misplaced Pages has tens of thousands of articles on individual human genes, many bot-made and maintained with very little human attention. TNIK caught my eye because a happened to read about clinical trials underway for inhibitors thought to be cancer-preventative. As noted in the other discussion, Misplaced Pages coverage of gene-directed trial therapies ranges from something like USP1 (which currently contains no information on investigative efforts), to CD47 (which is reasonably well-covered in this respect). BD2412 T 20:34, 13 December 2024 (UTC)
- added some recent papers, general research--Ozzie10aaaa (talk) 14:04, 14 December 2024 (UTC)
- Thank you - I will get around to adding some specifics. Cheers! BD2412 T 15:57, 16 December 2024 (UTC)
Drowning
The WHO has released their first-ever Global Report on Drowning Prevention. It has national statistics, risk factors, evidence-based prevention recommendations, and more.
Pbsouthwood, Belbury, Ex nihil, Scriptir EMsmile, would this interest any of you? WhatamIdoing (talk) 22:27, 13 December 2024 (UTC)
- Thanks, I will take a look. · · · Peter Southwood : 02:54, 14 December 2024 (UTC)
- I will take a look too. Thank you Scriptir (talk) 14:44, 30 December 2024 (UTC)
Do The Lancet's Personal View articles meet the standards for a secondary source?
Hi WikiProject Medicine,
The Lancet has a kind of article called a 'Personal View' that is peer reviewed. It has a lot of the formalities of a review article -- description of search strategy and selection criteria, extensive citations for claims, etc. Does this count as a review, and if not, does it still count as a suitable secondary source for biomedical information? Daphne Morrow (talk) 11:12, 14 December 2024 (UTC)
- Oh I forgot to add. 'Personal View' articles come up when you search The Lancet for review articles only, so clearly The Lancet's editors consider them as part of the Review category. But does WikiProject Medicine? Daphne Morrow (talk) 11:34, 14 December 2024 (UTC)
- Should be fine for non-contentious knowledge and non-novel claims. Novel personal views may be due and should probably be attributed. Any examples in mind? Bon courage (talk) 11:37, 14 December 2024 (UTC)
- Thank you for this.
- I was asking in general but here is an example:
- Hashimoto’s disease has a widely discussed issue with persistent symptoms in about 10-15% of patients despite euthyroid status. There’s a number of commonly discussed hypotheses for why this might be. An article like this https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00004-3/abstract
- discusses one of the more common hypotheses, that some patients lack peripheral tissue conversion of t4 into t3. I feel something like this makes for a suitable source in context? Daphne Morrow (talk) 13:03, 14 December 2024 (UTC)
- Should be fine for non-contentious knowledge and non-novel claims. Novel personal views may be due and should probably be attributed. Any examples in mind? Bon courage (talk) 11:37, 14 December 2024 (UTC)
- I think that an article like this would be sufficient for paraphrasing a background section of an article, if a higher quality review/textbook etc is not available. In my own editing I would not share the hypotheses of a mechanism responsible for persisting symptoms from a commentary article without higher quality supporting MEDRS sources.JenOttawa (talk) 13:13, 14 December 2024 (UTC)
- Thank you Jen, that makes perfect sense. Daphne Morrow (talk) 13:17, 14 December 2024 (UTC)
Requested move at Talk:Zoonotic origins of COVID-19#Requested move 14 December 2024
There is a requested move discussion at Talk:Zoonotic origins of COVID-19#Requested move 14 December 2024 that may be of interest to members of this WikiProject. TarnishedPath 14:24, 15 December 2024 (UTC)
- The proposal is to move the page Zoonotic origins of COVID-19 → COVID-19 zoonotic origin theory. WhatamIdoing (talk) 19:42, 16 December 2024 (UTC)
PANDAS
There are a lot of new SPAs at Talk:PANDAS; more eyes needed. SandyGeorgia (Talk) 09:38, 16 December 2024 (UTC)
- Could some people please put this article on their Watchlists? In the last month, only nine registered editors with this on their watchlists have checked this article. WhatamIdoing (talk) 19:42, 16 December 2024 (UTC)
- I added it to my watchlist. Is the article itself getting vandalized? If so it might need page protection. IntentionallyDense 21:36, 16 December 2024 (UTC)
- No, it's getting well-intentioned efforts from people who believe the article has the wrong POV. They may not be 100% wrong, so we need good editors here. WhatamIdoing (talk) 21:45, 16 December 2024 (UTC)
- Correct; and it is a difficult topic complicated by multiple factors. The topic has long been plagued by canvassing that occurs at popular tic-related message boards and online support groups for parents -- a phenomenon mentioned in multiple sources -- so editors who understand policy and guideline as well as medicine have been lacking to keep up with that. Some dated sections need rewriting (not so much for changed content, but to update the citations used that usually say same), but motivation wanes when much educating about policies and guidelines has to be done along the way, along with answering a lot of misinformation or overinterpretation of sources. Summary: more eyes needed, still and always. SandyGeorgia (Talk) 13:43, 17 December 2024 (UTC)
- Here is a lay article that provides an overview of the territory:
- SandyGeorgia (Talk) 14:31, 17 December 2024 (UTC)
- No, it's getting well-intentioned efforts from people who believe the article has the wrong POV. They may not be 100% wrong, so we need good editors here. WhatamIdoing (talk) 21:45, 16 December 2024 (UTC)
A good deal of the talk discussion at PANDAS is now about PANS, which was AFD'd 12 years ago (Misplaced Pages:Articles for deletion/Pediatric acute-onset neuropsychiatric syndrome). Is it time now to create that article? When PANS first came up, it was just another in a string of hypotheses (PANDAS, PITANDs, PANS, CANS); now it seems to be the prevailing one. I'm unsure of the technicalities of overriding that AFD, or even if that's the best course of action; if someone clues me in on how to proceed here, I could stub up the new PANS article. Ajpolino? SandyGeorgia (Talk) 21:11, 17 December 2024 (UTC)
- I think that would be reasonable, but step one is going to be finding some good sources. WhatamIdoing (talk) 23:17, 17 December 2024 (UTC)
- Secondary reviews since the 2012 AFD, at least:
- ... at least. So if someone advises on the process for overwriting an AFD'd article, I can separate out the relevant content. SandyGeorgia (Talk) 02:16, 18 December 2024 (UTC)
- At this point, I think that just boldly replacing the redirect with a decent article would be fine. It might be convenient to draft it in your sandbox, so you can replace it in a single edit. WhatamIdoing (talk) 06:53, 18 December 2024 (UTC)
- I could do that as soon as I get a free moment; I just wanted to be sure a bold replacement over a previous AFD wouldn't be problematic. I should be able to get to that later today, unless someone tells me doing so is unwise. SandyGeorgia (Talk) 15:31, 18 December 2024 (UTC)
- We could take it to Misplaced Pages:Deletion review if you'd like to avoid any possible risk of a {{db-repost}} complaint. (I could take it there for you, if you'd like.) WhatamIdoing (talk) 17:19, 18 December 2024 (UTC)
- I am drowning IRL ... maybe we could wait 'til after Christmas? I'm not sure anyone would object to the article being recreated, as I was the only one opining in the past! Whatever you think, I'm just SO out of time ... SandyGeorgia (Talk) 23:09, 18 December 2024 (UTC)
- WP:There's no deadline. In the meantime, here's a virtual life preserver: 🛟 WhatamIdoing (talk) 00:06, 19 December 2024 (UTC)
- I don't think we need a second article. A google shows most coverage is on PANS/PANDAS together. If PANDAS is a subset of PANS then what is needed perhaps is to move the existing PANDAS article to PANS and cover PANDAS within that. That allows us to use sources talking about "PANS/PANDAS" together but also sources covering just one where appropriate. -- Colin° 10:02, 19 December 2024 (UTC)
- I can't think of any reason to oppose that; would like to see more feedback, though. SandyGeorgia (Talk) 12:57, 19 December 2024 (UTC)
- I don't think we need a second article. A google shows most coverage is on PANS/PANDAS together. If PANDAS is a subset of PANS then what is needed perhaps is to move the existing PANDAS article to PANS and cover PANDAS within that. That allows us to use sources talking about "PANS/PANDAS" together but also sources covering just one where appropriate. -- Colin° 10:02, 19 December 2024 (UTC)
- WP:There's no deadline. In the meantime, here's a virtual life preserver: 🛟 WhatamIdoing (talk) 00:06, 19 December 2024 (UTC)
- I am drowning IRL ... maybe we could wait 'til after Christmas? I'm not sure anyone would object to the article being recreated, as I was the only one opining in the past! Whatever you think, I'm just SO out of time ... SandyGeorgia (Talk) 23:09, 18 December 2024 (UTC)
- We could take it to Misplaced Pages:Deletion review if you'd like to avoid any possible risk of a {{db-repost}} complaint. (I could take it there for you, if you'd like.) WhatamIdoing (talk) 17:19, 18 December 2024 (UTC)
- I could do that as soon as I get a free moment; I just wanted to be sure a bold replacement over a previous AFD wouldn't be problematic. I should be able to get to that later today, unless someone tells me doing so is unwise. SandyGeorgia (Talk) 15:31, 18 December 2024 (UTC)
- At this point, I think that just boldly replacing the redirect with a decent article would be fine. It might be convenient to draft it in your sandbox, so you can replace it in a single edit. WhatamIdoing (talk) 06:53, 18 December 2024 (UTC)
Re Is the article itself getting vandalized?
, another question is whether the talk page is being used appropriately or disruptively? SandyGeorgia (Talk) 22:36, 23 December 2024 (UTC)
Water fluoridation
If someone has an or two eyes on that - new account promotes findings of a review regarding associations of IQ and fluoridation (what is missing: decrease in IQ points). This review is flawed - Garbage in, garbage out - as it solely relies on the flawed papers from the past. --Julius Senegal (talk) 18:54, 19 December 2024 (UTC)
- Thanks for the note.
- This is a political 'thing' in the US at the moment, so having a decent article will be the best way to prevent well-intentioned but imperfect attempts to improve it. In particular, I think that the claims that have been in the news for the last year should be directly mentioned and addressed. Usually, if we put in something that says "____ was claimed, but this is wrong because..." then that will work, but if we remove it, then people assume that it's accidentally missing, and that we would consider if helpful for someone to add "____ is true!" to the article. WhatamIdoing (talk) 21:45, 19 December 2024 (UTC)
- That ist true, but the SPA is now even removing all criticism at all. I didn't delete it just moved it.
- that is why this is highly flawed and needs attention by more members here. The SPA is just reverting in a nonconstructive way.--Julius Senegal (talk) 22:13, 19 December 2024 (UTC)
- @The Anome, I see you were editing that page recently. @Doc James semi'd the page indefinitely years ago. What do you think about raising that to WP:EXTCONFIRMED? Or tagging it as part of WP:AP2, since that's what's driving the edit wars? WhatamIdoing (talk) 00:18, 20 December 2024 (UTC)
- Better sooner than later.
- You see that also on the discussion page. --Julius Senegal (talk) 17:49, 20 December 2024 (UTC)
Review AI-generated articles
Hi there! While reviewing at AfC, I recently came across several AI-generated medical articles, some of which are still in draftspace and some of which have been accepted and moved to mainspace. These articles do not immediately come across as AI-generated, but when run through Misplaced Pages GPTzero, they have high AI-generation scores.
- 2-Aminoadipic-2-oxoadipic aciduria
- Alpha-2-plasmin inhibitor deficiency
- Bosma arhinia microphthalmia syndrome
- Bile acid synthesis disorders
- Draft:Colchicine poisoning
- Draft:Al-Kaissi Syndrome
I would really appreciate it someone over here could help go through the articles to ensure accuracy. Thank you! Significa liberdade (she/her) (talk) 16:42, 22 December 2024 (UTC)
- @Significa liberdade, I looked at Bile acid synthesis disorders. It was created in multiple edits over the space of several hours. All the refs are real. (I know nothing about the subject matter.) Do you have any reason except for the tool to believe that this is LLM content?
- I am suspicious of "detector" tools, because they sometimes declare content that I wrote to be generated by an LLM. WhatamIdoing (talk) 22:55, 22 December 2024 (UTC)
- Hi, WhatamIdoing! I ran it through Misplaced Pages GPTzero. That particular article shows a 99.8% AI-generation score. Significa liberdade (she/her) (talk) 03:01, 23 December 2024 (UTC)
- @Significa liberdade, I ran some of the early revisions through the same tool, and it said human: 0.983, ai: 0.017, and mixed: 0.0. Try putting the version just before your own edits in the tool and see what you get. WhatamIdoing (talk) 05:48, 23 December 2024 (UTC)
- WhatamIdoing: Interesting... I'll have to bring this up to the individual who created the tool. I initially ran the edit before mine through the tool, and it told me 90-100% AI-generated. Significa liberdade (she/her) (talk) 01:15, 24 December 2024 (UTC)
- Although the tool may be wrong, I do find it telling that when I ask ChatGPT to write a Misplaced Pages article about Bile acid synthesis disorders, it basically writes the exact article currently published.
- Chat's lead reads, "Bile acid synthesis disorders (BASDs) are a group of rare, inherited metabolic conditions caused by defects in the enzymes involved in the production of bile acids. Bile acids are essential for the digestion and absorption of fats and fat-soluble vitamins, as well as for the regulation of cholesterol levels. BASDs can lead to a variety of symptoms, including liver dysfunction, malabsorption, and developmental delays."
- Aside from a few slight wording adjustments, this is exactly what is written in the article. The classification section is the same way. The other sections have similar starts. Chat's sections are just about a sentence each, so it's quite possible each section was started and then asked something along the lines of "Could you expand on that"? When I asked GPT to expand on classification, it started adding similar information as to what is in the article. Significa liberdade (she/her) (talk) 01:26, 24 December 2024 (UTC)
- I wonder if it is (now) adapting the Misplaced Pages article, or if it would have given you the same results before the Misplaced Pages article was created. WhatamIdoing (talk) 01:41, 24 December 2024 (UTC)
- WhatamIdoing: Interesting... I'll have to bring this up to the individual who created the tool. I initially ran the edit before mine through the tool, and it told me 90-100% AI-generated. Significa liberdade (she/her) (talk) 01:15, 24 December 2024 (UTC)
- @Significa liberdade, I ran some of the early revisions through the same tool, and it said human: 0.983, ai: 0.017, and mixed: 0.0. Try putting the version just before your own edits in the tool and see what you get. WhatamIdoing (talk) 05:48, 23 December 2024 (UTC)
- Hi, WhatamIdoing! I ran it through Misplaced Pages GPTzero. That particular article shows a 99.8% AI-generation score. Significa liberdade (she/her) (talk) 03:01, 23 December 2024 (UTC)
No CSD for badly referenced medical articles/gibberish?
So, Yangqi acupoint has sadly been created by one of my students (sorry). But it also made me suprised - I was going to CSD it but I could not see an applicable criterion? Piotrus at Hanyang| reply here 11:53, 23 December 2024 (UTC)
- One person's "badly referenced medical content" is another person's WP:TRUTH. I think you did a reasonable thing by moving it to the Draft: namespace. WhatamIdoing (talk) 19:23, 23 December 2024 (UTC)
- This is not the sort of thing that I would think would have a CSD criterion at all. BD2412 T 19:50, 23 December 2024 (UTC)
- I agree. It's not concrete and indisputable enough. WhatamIdoing (talk) 20:43, 23 December 2024 (UTC)
- This is not the sort of thing that I would think would have a CSD criterion at all. BD2412 T 19:50, 23 December 2024 (UTC)
Clean up of Thyroid hormone articles
Hi Wikiproject Medicine, seeking a little bit of preliminary input here.
I'm looking at how WP presents information around Thyroxine, Levothyroxine, Levothyroxine Sodium; and Tri-iodothyronine, Liothyronine and Liothyronine Sodium. Thinking a bit about the best way to present the info, because I know how interchangably some of these terms get used even in literature (eg liothyronine used to refer to endogenous tri-iodothyronine, or levothyroxine sodium being commonly referred to as levothyroxine), even though they technically refer to different things.
At the moment:
For T3, there's a page for Liothyronine the drug, and one for Tri-iodothyronine the hormone.
For T4, there's one page called Levothyroxine which is for the drug, and another page called Thyroid Hormones for Thyroxine the hormone (but this page covers both T4 and T3).
For consistency, I'm trying to decide if it would be of benefit to:
A) propose a merger of Tri-iodothyronine into Thyroid Hormones (with the result being three pages -- one for thyroid hormones, one for liothyronine the drug, one for levothyroxine the drug)
B) propose that Thyroxine the hormone gets its own article and the Levothyroxine page becomes more exclusively about the drug (with the result being five pages, one overview of thyroid hormones, one for thyroxine the hormone, one for levothyroxine the drug, one for tri-iodothyronine the hormone, one for liothyronine the drug).
Thoughts? Daphne Morrow (talk) 00:55, 26 December 2024 (UTC)
- thank you for post--Ozzie10aaaa (talk) 00:23, 31 December 2024 (UTC)
- When a substance is both a natural hormone and a drug, generally there are separate articles. For example insulin vs. insulin (medication), testosterone vs. testosterone (drug). So I would support having separate hormone and drug articles for T3 and T4.
- Thyroxine (T4; the natural hormone) was once a standalone article that was turned into a redirect to Levothyroxine (the synthetic drug). Thyroxine (and also levothyroxine) refers specifically to T4. Thyroid hormones refers to thyroxine and its active metabolites (T3, rT3, etc.)
- There are three somewhat overlapping topics here: the chemical substances, the hormone(s), and the drug that fall under the scope of WP:Chemistry, WP:MCB, and WP:Pharmacology respectively. The is a general rule in WP:Chemistry, one article for each chemical substance. Hence we should have separate articles for T4, T3, rT3, etc. that transclude {{Chembox}}. Finally within the scope of WP:MCB, a single article about the Thyroid hormones makes sense. Boghog (talk) 11:19, 31 December 2024 (UTC)
- Thank you, that makes sense. Daphne Morrow (talk) 21:22, 31 December 2024 (UTC)
- @Daphne Morrow: The new thyroxine page could look something like User:Boghog/Sandbox10 (please especially note the hat note). Boghog (talk) 12:21, 31 December 2024 (UTC)
- Amazing, I would support this for the new thyroxine page.
- I have a further question, do you think we need to be clearer on the pages about Levothyroxine and Liothyronine about the difference between plain levothyroxine and levothyroxine] sodium, plain liothyronine and liothyronine sodium? Daphne Morrow (talk) 21:29, 31 December 2024 (UTC)
- It appears commercial formulations of both liothyronine and levothyroxine almost always contain the sodium salt. This could be mentioned in an "available forms" section under "medical uses" (see WP:PHARMOS). In addition, it could be mentioned that available forms include oral tablets, oral capsules, oral solution, and injectable forms. Boghog (talk) 12:54, 1 January 2025 (UTC)
- I'm not sure that these details (e.g., tablets vs capsules) are important. I'd only include available forms if it's a bit unusual (e.g., IV-only antibiotics, since people expect those to be pills, or oral chemotherapy drugs, since people expect those to be infusions) or if there is something special to be said about a particular formulation. WhatamIdoing (talk) 00:45, 2 January 2025 (UTC)
- Did a quick look at sources and this is what I found:
- For levothyroxine sodium:
- IV is used for extreme thyroid hormone deficiency: https://www.aafp.org/pubs/afp/issues/2000/1201/p2485.html
- Oral solution is proposed to have benefits for children and people who find it difficult to swallow tablets (https://www.nhs.uk/medicines/levothyroxine/), may be taken with some substances that usually interfere with levothyroxine in tablet form (https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1080108/full), and may allow more precise dosing (Seen this multiple times in unreliable sources but need to find a reliable source that says it).
- For liothyronine sodium:
- IV is sometimes used for extreme thyroid hormone deficiency (https://www.sciencedirect.com/science/article/pii/S2214624521000186)
- Oral solution is presumably useful for children and people who have difficulty swallowing, but I didn’t find sources that back that up, so I will leave that out pending future info. Liquid may allow more precise dosing: (https://www.jstage.jst.go.jp/article/endocrj/63/6/63_EJ16-0040/_article).
- I think it would be good to note slow-release and regular release formulations as regular release creates peaks of T3 that make it difficult to monitor and are unlike the stability of endogenous T3 levels. “slow-release oral form of liothyronine showed a delayed, smaller serum T3 peak when compared with levothyroxine plus the standard liothyronine preparation.” (https://www.thelancet.com/journals/landia/article/PIIS2213-8587(22)00004-3/abstract)
- I'd like some guidance on whether details like this are good to include. Daphne Morrow (talk) 05:32, 2 January 2025 (UTC)
- If a pharmaceutical company took the trouble of developing and distributing a new dosage form, this implies there is a medical need for it. As long as there is a reliable source that documents a use case for a particular dosage form, I think it is fair game for an "available forms" section. This is precisely what this section is for. Boghog (talk) 10:26, 2 January 2025 (UTC)
- Thank you again for your help.
- Further to the question about the regular vs salt forms of levothyroxine and liothyronine, the information in the drugbox is inconsistent (eg. the image for levothyroxine shows the regular form, the image for liothyronine shows the salt form; the CAS for liothyronine goes to C15H12I3NO4, the pubchem link goes to C15H13I3NNaO5). Should I try to standardise these and if so, should I try to make all the information about the regular form or the salt form? Daphne Morrow (talk) 11:07, 2 January 2025 (UTC)
- My preference would be to standardize structures in {{Infobox drug}} on the parent and not salt forms. Per WP:MEDTITLE, drug articles should be named after the INN. In turn:
Boghog (talk) 19:03, 2 January 2025 (UTC)An INN is usually designated for the active part of the molecule only, to avoid the multiplication of entries in cases where several salts, esters, etc. are actually used.
— World Health Organization, "Guidance on INN", Health products policy and standards- Thank you that makes perfect sense. I’ll put cleaning up the box info on my todo list.
- Are you intending to publish Thyroxine? Is there anything I should do to help? Daphne Morrow (talk) 19:57, 2 January 2025 (UTC)
- Done. Boghog (talk) 11:19, 5 January 2025 (UTC)
- You’re the best, thank you so much for this. Daphne Morrow (talk) 11:24, 5 January 2025 (UTC)
- Done. Boghog (talk) 11:19, 5 January 2025 (UTC)
- My preference would be to standardize structures in {{Infobox drug}} on the parent and not salt forms. Per WP:MEDTITLE, drug articles should be named after the INN. In turn:
- I'm not sure that these details (e.g., tablets vs capsules) are important. I'd only include available forms if it's a bit unusual (e.g., IV-only antibiotics, since people expect those to be pills, or oral chemotherapy drugs, since people expect those to be infusions) or if there is something special to be said about a particular formulation. WhatamIdoing (talk) 00:45, 2 January 2025 (UTC)
- It appears commercial formulations of both liothyronine and levothyroxine almost always contain the sodium salt. This could be mentioned in an "available forms" section under "medical uses" (see WP:PHARMOS). In addition, it could be mentioned that available forms include oral tablets, oral capsules, oral solution, and injectable forms. Boghog (talk) 12:54, 1 January 2025 (UTC)
Need help on adding content to WikiProject Medicine
Hello all. I specialize in the field of medicine and wanted to add content to wiki project medicine. However, I am very new to Misplaced Pages editing. Some hours back, I created a page on Wiki project . But I can't figure out what to do now. Nor can I see my name in participants' full list. Can someone tell me If by mistake I created a wrong page? Or may be suggest me how I can actively participate, if this is the right page. Kindly help. Thanks. Neotaruntius (talk) 13:47, 26 December 2024 (UTC)
- @Neotaruntius, welcome! The bot adds names once a day to Misplaced Pages:WikiProject Medicine/Members. Your name is there now, so you must have done everything right.
- One project underway is to get at least one reference in every article this group supports. We only have 64 left to go. If you want to pick one (or a dozen!) from this list and add a suitable reliable source to it, that would be really helpful. (It's even more helpful if you also remove the
{{unreferenced|date=January 2010}}
tag from the top of the article.) - Alternatively, if you want to work on creating a new article, look at the two sections following this. I'm sure they would appreciate some help. WhatamIdoing (talk) 01:18, 28 December 2024 (UTC)
- @WhatamIdoing: Thanks very much sir. Everything is appearing so new to me. As you can understand from my edits, I am very new to Misplaced Pages editing. Let me get used to this new interface. I will most definitely do as suggested. Many thanks for this huge favor.Neotaruntius (talk) 06:32, 28 December 2024 (UTC)
- We're always glad to see new people helping out.
- BTW, for adding sources to articles, I prefer using the visual editor. You should use whichever you like best. So you can compare them, for the article Institut de recherches cliniques de Montréal, here's a link that will take you straight to the older wikitext editor and here's a link that will give you the same article in the visual editor. WhatamIdoing (talk) 01:47, 29 December 2024 (UTC)
- @WhatamIdoing: Thanks very much sir. Everything is appearing so new to me. As you can understand from my edits, I am very new to Misplaced Pages editing. Let me get used to this new interface. I will most definitely do as suggested. Many thanks for this huge favor.Neotaruntius (talk) 06:32, 28 December 2024 (UTC)
- I just wanted to echo user WAID's warm welcome. It is great to see new medical editors here! Happy editing and feel free to reach out anytime if you have any questions or want us to take a peek at your edits as you learn. JenOttawa (talk) 02:41, 1 January 2025 (UTC)
New drug names
Lists of new generic drug names under consideration or recommended as International Nonproprietary Names can be found at https://www.who.int/teams/health-product-and-policy-standards/inn/inn-lists Similarly, drug names under consideration as United States Adopted Names can be seen at https://www.ama-assn.org/about/united-states-adopted-names/usan-drug-names-under-consideration In the case of some new drugs, there may not be enough published information to allow an article to be written, but for others, creating an article may be possible. Eastmain (talk • contribs) 00:12, 27 December 2024 (UTC)
- @Eastmain, in my experience, by the time a drug candidate has reached Phase 3 clinical trials, there's plenty of sources for it, and there are frequently enough sources by Phase 2. One of the challenges has been figuring out which names are the same. We'll find a paper about "ABC-1234", and then the little biotech company gets bought, and it becomes "BIG-1234", and then it gets a brand name and a generic name, and now we have to search under multiple names.
- For example, the first one in the recent Recommended list is https://pubchem.ncbi.nlm.nih.gov/compound/Abenacianine, aka abenacianinum, aka VGT-309. Misplaced Pages should have an article on abenacianinum, or at least an article on Vergent Bioscience with redirects from all the names. Since the biomedical sources for pre-approval drugs tend to be primary, and almost always affiliated with the company (one example for this drug), the Misplaced Pages articles are often written more from the "business" than the "medical" side: They had these activities, they got this much money invested.
- Just collecting all the names into a list could be helpful. I wonder if you'd like to talk to Misplaced Pages talk:WikiProject Pharmacology about this, as they are more specialized. WhatamIdoing (talk) 01:37, 28 December 2024 (UTC)
- @Eastmain: Thanks sir. I am working on these suggestions. I will get back to you again, if I have any problems. I am overwhelmed at the amount of help I am getting from completely unknown persons. The only common thread between all of us appears to be "love of knowledge", and a "genuine desire to contribute". Thank you sir once again. Neotaruntius (talk) 06:35, 28 December 2024 (UTC)
- I'm "ma'am", rather than sir, though most of the regulars on this page are men.
- You have given me a good excuse to remind everyone how to find out. First, if you go to Special:Preferences#mw-prefsection-personal-i18n then you can set your own gender. Remember that changing your prefs requires ticking/unticking the box plus scrolling down to click the blue Save button. (Actually changing your settings is optional, but I've done it, and if you look at the page, then the next step will make a little more sense. Whatever you choose for gender settings will be publicly visible.)
- Second, go to Special:Preferences#mw-prefsection-gadgets-gadget-section-browsing and find "Navigation Popups". This replaces the usual box when you hover over a link with a more feature-filled one. If you turn on WP:NAVPOPS and ►reload this page (don't just use the back button on your browser for the first try), then when you hover over anyone's user name, you'll see the person's gender (if any is set in preferences; blank is the default of singular they), user rights/whether they're an admin, how long they've been editing, and how many edits they've made total.
- There are other ways to find out this pref setting, but I usually find that this one is the most convenient for me. WhatamIdoing (talk) 23:03, 30 December 2024 (UTC)
- Good catch WAID. I missed that Abenacianine is the same as VGT-309. Abenacianine is the English INN, abenacianinum is Latin, and Misplaced Pages drug articles should be named after the English INN. I renamed VGT-309 as Abenacianine and added VGT-309 as a synonym to the drug infobox. Boghog (talk) 10:50, 29 December 2024 (UTC)
- @Eastmain: Thanks sir. I am working on these suggestions. I will get back to you again, if I have any problems. I am overwhelmed at the amount of help I am getting from completely unknown persons. The only common thread between all of us appears to be "love of knowledge", and a "genuine desire to contribute". Thank you sir once again. Neotaruntius (talk) 06:35, 28 December 2024 (UTC)
Mandibular cancer
I was just working on an article about a state supreme court justice who died of complications from mandibular cancer, also known as cancer of the lower jaw, and was shocked to find that there is a rather prominent form of cancer for which we have no article. I know nothing about the topic, but perhaps someone who does have knowledge of this might write about it. BD2412 T 22:17, 27 December 2024 (UTC)
- G.J.ThomThom, are you still looking for articles your students could create?
- I see that Jaw cancer redirects to Oral cancer. Cancer of the jaw is a red link. I'm not sure if these are treated exactly the same, but I'd assume that mandibular cancer is a subtype of oral cancer. WhatamIdoing (talk) 01:45, 28 December 2024 (UTC)
- Hello
- Yes things kick off for us in the new semester starting in January so you will be hearing more from me. I will take note of this. Thank you G.J.ThomThom (talk) 13:05, 29 December 2024 (UTC)
- And please do pass on other cases like this if they emerge G.J.ThomThom (talk) 13:08, 29 December 2024 (UTC)
- @G.J.ThomThom, maybe also add Salt-sensitve hypertension to your list. We have a section at Salt and cardiovascular disease#Sodium sensitivity, but it cites sources from the previous century. It was in the news a while ago, with evidence of a connection to West African ancestry. WhatamIdoing (talk) 05:30, 30 December 2024 (UTC)
- As far as I understand, cancer of the mandible would not be classified as a type of oral cancer or even head and neck cancer. Oral cancer generally refers to squamous cell carcinoma (a soft tissue cancer arising in the epithelial layer). As for cancer arising in the hard tissue of the jaw, I don't know exactly how they would be classified... maybe redirect to Bone tumor is best for now.
- As the current article for oral cancer states: "Other cancers can occur in the mouth (such as bone cancer, lymphoma, or metastatic cancers from distant sites) but are also considered separately from oral cancers."
- Also I don't know if there is a need for a dedicated article for each bone in terms of cancer. That is because I guess each article would be quite similar when it comes to the list of possible cancers which may originate or spread to that bone. The mandible is however possibly an exception because of the existence of that group of cancers related to the tissues which form the teeth (see Odontogenic tumor). Moribundum (talk) 10:18, 7 January 2025 (UTC)
- Another quick note: as far as I am aware, cancer originating in the hard tissues of the jaw is significantly less prominent compared to squamous cell carcinoma of the soft tissues. I don't think it is the case that the encyclopedia is missing some very important category of cancer here. Moribundum (talk) 10:22, 7 January 2025 (UTC)
DSM copyright warnings
I have created {{DSM copyright}}. It's a message for talk pages, to warn editors that they can't copy the full criteria out of the Diagnostic and Statistical Manual of Mental Disorders for copyright reasons.
We've known about this problem for years, but there are always new editors joining, and occasionally someone will replace a description with the copyrighted text of the DSM entry. Even though they're really just trying to help, the fact is that the copyright holder could actually sue them (and would win). I'd like to give these editors the information they need to do the right thing.
To save time and fingers, I'd like to ask someone at Misplaced Pages:Bot requests or Misplaced Pages:AutoWikiBrowser/Tasks to spam this warning onto the talk pages of all the conditions listed in List of mental disorders. (Anyone can add it manually to other pages, and if there's an item in that list that doesn't have a DSM entry, then it could be manually removed as irrelevant and unnecessary in that case.) Does anyone support or oppose this? WhatamIdoing (talk) 05:48, 28 December 2024 (UTC)
- I support IntentionallyDense 07:42, 28 December 2024 (UTC)
- Support asking a bot to place message on talk pages (I've actually had to argue this recently here on this talk page!!) SandyGeorgia (Talk) 20:35, 28 December 2024 (UTC)
- I support placing message and bot publishing it to talk pages. Daphne Morrow (talk) 00:39, 29 December 2024 (UTC)
- @WhatamIdoing: I support it sir wholehearted. However, there could literally be thousands of pages, where one could unintentionally add a DSM category. Being a newbie, I was wondering, about the possibility of having a Bot, which could automatically warn an editor, that he was adding something that was copyrighted. This would be far simpler than somebody keeping on removing unwanted entries. Of course, I am not sure, if such a bot exists, or could even be created. Kindly advise. Neotaruntius (talk) 06:44, 30 December 2024 (UTC)
- At the moment, we can't give real-time warnings, and since not all books are digitized, it'll never be perfect. But we do have a system that runs after you've added some text, to check for probable copyvios. Because the copyvio systems are really matching to "matches this website" – and some websites aren't copyrighted – it requires manual review after that, but we think we're catching at least most of it that way. WhatamIdoing (talk) 07:14, 30 December 2024 (UTC)
- @WhatamIdoing:Thanks sir for your valuable comments. Yes, "real-time warnings" are what I meant. A system checking for "copyright violations" also sounds good enough. I did find a page for copyvio template . Thanks very much. Neotaruntius (talk) 07:32, 30 December 2024 (UTC)
- Agreed: the book is copyrighted material. I support the tag and bot(s). Gobucks821 (talk) 19:27, 30 December 2024 (UTC)
- @WhatamIdoing:Thanks sir for your valuable comments. Yes, "real-time warnings" are what I meant. A system checking for "copyright violations" also sounds good enough. I did find a page for copyvio template . Thanks very much. Neotaruntius (talk) 07:32, 30 December 2024 (UTC)
- At the moment, we can't give real-time warnings, and since not all books are digitized, it'll never be perfect. But we do have a system that runs after you've added some text, to check for probable copyvios. Because the copyvio systems are really matching to "matches this website" – and some websites aren't copyrighted – it requires manual review after that, but we think we're catching at least most of it that way. WhatamIdoing (talk) 07:14, 30 December 2024 (UTC)
Prostate cancer TFA February 4
Please watchlist the article for vandalism or inappropriate edits on February 4, when it appears on Misplaced Pages's mainpage.
Great work by Ajpolino ! SandyGeorgia (Talk) 16:53, 28 December 2024 (UTC)
Fun Christmas paper
Some of you might be interested in reading this:
- Cro, Suzie; Phillips, Rachel (2024-12-14). "All I want for Christmas…is a precisely defined research question". Trials. 25 (1): 784. doi:10.1186/s13063-024-08604-w. ISSN 1745-6215. PMC 11645783. PMID 39673058.
{{cite journal}}
: CS1 maint: PMC format (link) CS1 maint: unflagged free DOI (link)
WhatamIdoing (talk) 01:53, 29 December 2024 (UTC)
Does WP:MEDRS apply for pet studies?
See talk-page discussion at Vegetarian and vegan dog diet, a user added a trial and it was removed by another editor. My understanding is that MEDRS does also apply for biomedical claims made about pets and that we shouldn't use primary sources such as a single feeding trial. I could be wrong though; it's been a while since I edited anything related to pets. Seeking clarification on this. Psychologist Guy (talk) 22:33, 30 December 2024 (UTC)
- As pet foods and medications are regulated by the FDA under an almost identical pathway as human drug approvals and indications, I’d agree that WP:MEDRS applies.
- Could you find somebody in a veterinary Project to get their impression (since that’s more into their speciality)? Thnx, again, I agree it should apply! Gobucks821 (talk) 22:36, 30 December 2024 (UTC)
- VETMED was always a small group, and I'm not sure who's around these days.
- Historically, the community has been more tolerant of primary sources being cited for content that could not possibly have any human medical application. Also, WP:ECREE ("Extraordinary Claims Require Extraordinary Evidence") applies to all content. If the results are surprising ("e.g., obligate carnivores are healthy on a long-term vegan diet"), then I'd want more than a primary source. If the results are WP:SKYBLUE ("Mammals need to eat food"), then a peer-reviewed primary journal article (especially its background/overview section) might be a strong enough source. In between those two extremes, you'll have to use your judgment.
- Sometimes the fastest solution is to find another source. WhatamIdoing (talk) 22:50, 30 December 2024 (UTC)
- Thanks for the suggestions and I agree. Unfortunately there are hardly any studies that have been done on vegan dog diets and no good reviews. The feeding trial in question was this one . There is a serious lack of secondary sources discussing this kind of topic. I think it would be best to wait until more research has been published. I disagree with citing just one trial. We need better secondary sourcing. Psychologist Guy (talk) 22:58, 30 December 2024 (UTC)
- And it's recent, so we're unlikely to find it in textbooks yet. It's possible that there is some sort of popular press comment on it. Those tend to be lousy sources in a different way, though, even the ones that are technically secondary sources. WhatamIdoing (talk) 23:36, 30 December 2024 (UTC)
- Thanks for the suggestions and I agree. Unfortunately there are hardly any studies that have been done on vegan dog diets and no good reviews. The feeding trial in question was this one . There is a serious lack of secondary sources discussing this kind of topic. I think it would be best to wait until more research has been published. I disagree with citing just one trial. We need better secondary sourcing. Psychologist Guy (talk) 22:58, 30 December 2024 (UTC)
Request additional eyes on American Society of Anesthesiologists
A recent addition was made to the article. The addition doubled the text length of the article and focuses on negative aspects of the organization's lobbying (sources appear sound). It would be good to get people who are familiar with articles about professional medical organizations to look at the addition to make sure it adheres to NPOV. Springee (talk) 19:34, 1 January 2025 (UTC)
- If the information from 2004, that the ASA “spent the second-largest sum of money on lobbying of all professional physician associations in the United States.” is true for the long term, then I would expect lobbying to take up a greater portion of their page than other pages about professional medical organisations.
- I’m concerned about the focus on recent contentious lobbying however. Sounds like the ASA been lobbying for decades with a lot of money, and if so, this section should reflect whatever those other efforts were. Daphne Morrow (talk) 21:15, 1 January 2025 (UTC)
- "In the 2000s, the ASA lobbied to force anesthesiologists to be in the hospital room whenever an anesthesia drug was administered to patients during colonoscopies " is unreferenced. NYT article does not mention it. T g7 (talk) 21:20, 1 January 2025 (UTC)
- NYT article does not mention propofol either. T g7 (talk) 21:22, 1 January 2025 (UTC)
- This is a topic that is outside my normal area of knowledge but the new material, made the article shift from what seemed like kind of a high level, boiler plate description to something that looked like an attack article trying to pass as encyclopedic. Like I said, some level of content may make sense but not 50% of the article. I will note that a recent search for articles that mentioned the organization didn't say anything about these controversies. This suggests the material is getting too much weight. Still, I think getting more eyes on the topic would be best. Springee (talk) 21:42, 1 January 2025 (UTC)
- Also there is lack of context, as the Tampa Bay Times article points out that the Nurse Anesthetist society spent a lot of money lobbying in opposition to the ASA. And the NYT article points out that the *third* highest spender in lobbying was the nurse anesthetist society. And there is no attention paid to the ASA's contention that their lobbying effort is to ensure patient safety. In my opinion, it reads more like an advocacy piece than an encyclopedic piece. That being said, there are some good points here- for example, pointing out the role of money and lobbying in health care in the US is very important. I think the battle between the nurse anesthetists and the anesthesiologists is noteworthy but it would need more context. T g7 (talk) 21:43, 1 January 2025 (UTC)
- NYT article does not mention propofol either. T g7 (talk) 21:22, 1 January 2025 (UTC)
- Also the part about the anomalous billing does not represent fully what is stated in the references. T g7 (talk) 21:51, 1 January 2025 (UTC)
- In fact, one of the sources states "the authors have stressed that their findings should not be interpreted to indicate fraud because fraud involves intent, which could not be determined." So in my opinion, this is somewhat misrepresentating the reference. T g7 (talk) 21:58, 1 January 2025 (UTC)
Discussion at COVID-19 Lab Leak Theory about inclusion of anti-Chinese racism in lead
Talk:COVID-19_lab_leak_theory#Should_we_mention_in_the_lead_the_"increased_anti-Chinese_racism." Bluethricecreamman (talk) 15:31, 2 January 2025 (UTC)
- commented--Ozzie10aaaa (talk) 12:54, 4 January 2025 (UTC)
rT3 and T3 testing
Hi all,
Does anyone know where I’d find a MEDRS source that documents whether high rT3 levels can interfere with Free T3 immunoassay and/or ultrafiltration LC-MSMS tests?
All I can find is information that Free T3 immunoassays are prone to interference and that Free T3 affects rT3 radioimmunoassay tests, but no information about vice-versa.
Edit: This primary source seems concerned that rT3 and T3 could interfere with tests of each other because they are isobars of each other, but satisfied that there are methods to separate them in LC-MS/MS tests. https://link.springer.com/article/10.1007/s00216-019-01724-2
I'll keep looking for more info about current immunoassays and for secondary sources.
Daphne Morrow (talk) 02:57, 5 January 2025 (UTC)
- rT3 is rarely tested in clinical practice, and the utility of it outside of the context of central hypothyroidism vs euthyroid syndrome is highly debated in research. I'm not sure if or where information on this specefically could be found. IntentionallyDense 03:32, 5 January 2025 (UTC)
- Ah yes, I had gathered this from my sources so far, it’s good to have it confirmed by others.
- I was thinking maybe someone might know a pathology manual or some testing data from the original verification of the tests? Daphne Morrow (talk) 03:47, 5 January 2025 (UTC)
Colostrum health claims NPOV concerns
The colostrum article seems to be NPOV and promotional. I am going to look at it. Would appreciate others as well. T g7 (talk) 14:22, 5 January 2025 (UTC)
Natural childbirth NPOV issues
As I am not an expert, I want to bring to your attention that the article natural childbirth has NPOV issues. See Talk:Natural_childbirth#WP:NPOV_issues. Note also the article Unassisted childbirth describing a related practice. Mathwriter2718 (talk) 13:43, 6 January 2025 (UTC)
Viral spread of rumour about HMPV
There's an informal RM at Talk:HMPV outbreak in Northeast Asia (2024–present)#Proposal to Update Article Title. I suggest that people from this wikiproject add some arguments for or against the proposal to rename the article, or with specific proposals for a new name. Boud (talk) 15:57, 6 January 2025 (UTC)
RfC about TAAR1 agonism as the mediator of amphetamine monoamine release
Hello, all. Just fyi, I received a random Rfc notification due to my signup for the Feedback request service. You can find the Rfc discussion on TAAR1 agonism as the mediator of amphetamine monoamine release here. (This is just a notification and not an endorsement; in particular, I have not checked it for WP:RFCBEFORE compliance.) Thanks, Mathglot (talk) 02:55, 7 January 2025 (UTC)
Category: